immunemedi
disord
mmunemedi
dermatos
well
recogn
uncommon
skin
diseas
dog
cat
dermatos
report
account
respect
canin
felin
dermatos
examin
dermatolog
servic
univers
small
anim
practicep
subdivid
primari
autoimmun
secondari
immunemedi
latter
believ
primarili
diseas
wherein
tissu
destruct
result
immunolog
event
direct
normal
selfantigen
autoimmun
diseas
antibodi
activ
lymphocyt
develop
normal
bodi
constitu
induc
lesion
diseas
passiv
transfer
may
result
failur
elimin
highaffin
selfreact
lymphocyt
primari
lymphoid
organ
failur
regul
activ
lowaffin
selfreact
lymphocyt
major
level
control
autoreact
clone
lymphocyt
suppress
suppressor
cell
specif
clone
develop
autoimmun
diseas
reflect
lack
control
bypass
normal
control
mechan
year
varieti
possibl
defect
describ
exact
abnorm
mechan
induc
diseas
still
remain
unknown
possibl
includ
suppressor
cell
bypass
suppressor
cell
dysfunct
abnorm
major
histocompat
complex
mhc
ii
express
interact
cytokin
receptor
ligand
abnorm
autoantigen
modif
crossreact
antigen
inappropri
interleukin
il
product
idiotypeantiidiotyp
imbal
mutat
receptor
affin
failur
clonal
delet
lowaffin
autoreact
thymocyt
addit
sexual
dimorph
immun
respons
femal
sex
hormon
tend
acceler
immun
respons
male
sex
hormon
tend
suppress
respons
secondari
immunemedi
diseas
antigen
foreign
bodi
commonli
incit
antigen
drug
bacteria
virus
stimul
immunolog
reaction
result
host
tissu
damag
superantigen
gene
product
recogn
larg
fraction
cell
potenti
interfer
recognit
elimin
convent
antigen
gene
product
may
play
role
genesi
immunemedi
diseas
socal
epitop
spread
may
also
import
autoimmun
diseas
us
situat
patient
bodi
make
antibodi
one
protein
earli
diseas
diseas
evolv
patient
bodi
make
addit
antibodi
molecul
similar
structur
even
unlik
structur
physic
close
associ
within
tissu
diagnosi
dermatos
requir
demonstr
characterist
dermatopatholog
chang
optim
autoantibodi
immun
complex
mediat
see
refer
tsee
refer
eg
cytotox
cell
immunolog
injuri
establish
presenc
characterist
dermatopatholog
requir
cutan
biopsi
see
chap
gener
follow
guidelin
observ
multipl
biopsi
alway
taken
sampl
select
repres
lesion
suspect
immunemedi
diseas
punch
biopsi
sampl
taken
gentli
possibl
wedg
biopsi
scalpel
excis
may
necessari
whenev
possibl
biopsi
specimen
taken
anim
effect
glucocorticoid
immunosuppress
dermatopatholog
examin
perform
veterinari
pathologist
special
interest
dermatopatholog
veterinari
dermatologist
train
dermatopatholog
establish
mediat
immunolog
damag
may
requir
biopsi
andor
analysi
patient
serum
auto
abnorm
antibodi
biopsi
immunopatholog
examin
often
must
process
special
way
may
requir
fresh
tissu
frozen
tissu
special
fix
sampl
depend
test
perform
veterinari
immunopatholog
laboratori
abl
tell
requir
test
use
detect
presenc
autoantibodi
variou
immunoreact
eg
immunoglobulin
complement
compon
microbi
antigen
skin
lesion
includ
immunofluoresc
immunohistochem
immunoperoxidas
test
fig
gener
follow
guidelin
use
collect
biopsi
specimen
biopsi
specimen
direct
antibodi
test
select
area
secondarili
infect
gener
repres
earliest
lesion
typic
diseas
possibl
except
discoid
lupu
erythematosu
wherein
older
lesion
may
prefer
vascul
lesion
less
hour
old
best
bullou
diseas
blister
sampl
instead
adjac
normal
skin
erythemat
skin
use
site
wherein
immunoglobulin
often
present
normal
tissu
eg
nasal
planum
dog
cat
footpad
dog
sampl
interpret
appropri
see
chap
sampl
direct
immunofluoresc
test
need
fix
mail
michel
fix
sampl
direct
immunoperoxidas
test
may
formalinfix
result
studi
tissu
process
quickfreez
kept
michel
fix
week
compar
studi
dog
cat
suggest
specimen
may
reliabl
preserv
michel
fix
least
day
instanc
specimen
success
preserv
ph
michel
fix
must
care
maintain
ensur
accur
result
sampl
direct
antibodi
detect
sent
veterinari
immunopatholog
laboratori
test
abnorm
antibodi
immun
complex
deposit
consid
highli
valuabl
human
medicin
mani
immunemedi
dermatos
similar
canin
felin
diseas
howev
valu
consider
less
report
veterinari
immunopatholog
research
laboratori
show
techniqu
result
appear
improv
howev
test
fraught
numer
procedur
interpret
pitfal
includ
method
specimen
handl
choic
substrat
use
method
substrat
handl
specif
conjug
fluoresceinproteinantibodi
concentr
unitag
conjug
indepth
discuss
factor
beyond
scope
chapter
reader
refer
beutner
colleagu
detail
incid
posit
result
canin
disord
typic
vari
direct
immunofluoresc
test
posit
result
much
commonli
achiev
immunoperoxidas
techniqu
techniqu
howev
incid
falseposit
result
also
much
higher
fact
intercellular
basement
membran
zone
deposit
immunoglobulin
complement
detect
time
time
wide
varieti
inflammatori
dermatos
order
appropri
interpret
test
one
need
good
biopsi
specimen
histopatholog
examin
howev
one
appropri
specimen
histopatholog
examin
test
expens
usual
necessari
thu
well
otherst
think
test
need
routin
done
workup
suspect
case
immunemedi
skin
diseas
dog
cat
autoimmun
dermatos
classifi
basi
specif
autoallergen
target
determin
basi
routin
immunofluoresc
immunohistochem
test
specif
identif
requir
techniqu
immunoprecipit
immunoblot
rare
done
routin
veterinari
diagnost
laboratori
limit
certain
veterinari
immunolog
research
laboratori
result
may
still
lump
togeth
differ
diseas
variant
share
clinic
histopatholog
routin
immunopatholog
featur
indirect
immunofluoresc
test
test
serum
presenc
circul
autoantibodi
past
rare
yield
posit
result
dog
cat
result
conflict
therefor
recommend
costeffect
test
recent
result
posit
varieti
diseas
includ
pemphigu
foliaceusp
pemphigu
vulgari
paraneoplast
pemphigusl
bullou
epidermolysi
bullosa
acquisit
alopecia
areata
diseas
case
studi
canin
pemphigu
foliaceu
wherein
recent
studi
report
case
yield
posit
resultsp
technolog
avail
consid
obtain
tissu
serum
sampl
research
perform
test
correctli
frequent
abl
determin
whether
variant
describ
human
also
exist
dog
cat
whether
differenti
lead
prognost
therapeut
valu
result
immunopatholog
test
never
appropri
interpret
absenc
histopatholog
find
hand
histopatholog
find
suffici
characterist
diagnost
major
case
clinician
time
owner
money
better
spent
care
select
procur
repres
skin
specimen
forward
knowledg
dermatopathologist
techniqu
sensit
becom
readili
avail
type
test
undoubtedli
becom
common
recommend
collect
serum
dog
cat
activ
suspect
autoimmun
diseas
save
freezer
test
result
review
recommend
pathologist
indirect
immunofluoresc
test
may
still
perform
appropri
laboratori
serum
may
submit
appropri
research
center
support
futur
progress
sampl
may
also
use
later
date
pretreat
sampl
serum
biochem
paramet
group
immunemedi
dermatos
character
inappropri
immun
respons
adequ
control
may
requir
use
potent
immunosuppress
immunomodul
drug
past
primarili
meant
high
level
glucocorticoid
occasion
cyclophosphamid
azathioprin
initi
attempt
treatment
although
often
success
led
mani
side
effect
see
chap
recent
year
howev
varieti
differ
treatment
approach
evalu
therapeut
option
avail
clinician
manag
diseas
diseas
optim
treat
way
howev
carri
prognosi
therefor
import
clinician
make
specif
diagnosi
possibl
although
much
work
new
approach
manag
diseas
underway
human
medicin
littl
inform
appli
veterinari
medicin
drug
use
treat
immunemedi
skin
diseas
gener
call
immunosuppress
agent
howev
exact
mechan
drug
unknown
may
act
method
differ
classic
immunosuppress
agent
consid
togeth
whatev
mechan
action
share
featur
benefici
manag
immunemedi
skin
diseas
glucocorticoid
common
class
drug
use
immunosuppress
agent
discuss
chapter
howev
mani
drug
use
practic
effect
specif
diseas
tabl
special
use
glucocorticoid
initi
treatment
sever
immunemedi
dermatos
puls
therapi
glucocorticoid
puls
therapi
mglkg
methylprednisolon
sodium
succin
given
intraven
hour
consecut
day
use
induc
remiss
case
canin
pemphigu
respond
oral
glucocorticoid
therapi
expens
without
complic
see
chap
cyclophosphamid
cytoxan
bristolmey
squibb
metabol
alkyl
agent
inhibit
mitosi
interf
dna
replic
ribonucl
acid
rna
use
alon
combin
chemotherapeut
agent
treatment
variou
neoplasm
well
immunosuppress
activ
nonmalign
diseas
organ
transplantationt
abl
kill
cell
phase
cell
cycl
type
cytotox
drug
effect
slowgrow
tumor
phasespecif
drug
act
specif
time
cell
cycl
effect
rapidli
divid
cell
lymphocyt
especi
sensit
cyclophosphamid
drug
immunosuppress
humor
cellmedi
immun
system
effect
b
cell
cell
cyclophosphamid
suppress
antibodi
product
maxim
effect
occur
drug
given
shortli
antigen
stimulu
suppress
primari
secondari
humor
respons
major
toxic
sequela
includ
steril
hemorrhag
cystiti
bladder
fibrosi
teratogenesi
infertil
alopecia
poor
hair
growth
nausea
inflamm
gastrointestin
tract
increas
suscept
infect
depress
bone
marrow
hematopoiet
system
cat
may
lose
whisker
hemorrhag
cystiti
occur
dog
chronic
therapi
month
duratiori
effect
monitor
period
hemogram
urinalys
clinic
indic
includ
lymphoreticular
neoplasm
drug
best
combin
glucocorticoid
vincristin
given
high
dose
glucocordrug
well
dose
azathioprin
increas
longterm
therapi
associ
develop
demodicosi
recurr
bacteri
pyoderma
dermatophytosi
least
case
pancreat
may
occur
though
report
dog
also
receiv
glucocorticoid
also
note
pancreat
dog
case
azathioprin
could
continu
glucocorticoid
discontinu
without
episod
pancreat
patient
monitor
initi
everi
week
complet
blood
count
platelet
countsf
patient
condit
stabl
monitor
taper
everi
month
symptom
occur
least
yearli
chemistri
panel
also
run
hepat
pancreat
major
condit
monitor
chemistri
panel
small
anim
azathioprin
may
benefici
pemphigu
complex
bullou
pemphigoid
type
lupu
erythematosu
well
autoimmun
immunemedi
disord
commonli
use
case
canin
pemphigu
foliaceu
respond
glucocorticoid
azathioprin
usual
use
alon
combin
system
glucocorticoid
often
lag
phase
clinic
improv
occur
week
remiss
achiev
dosag
drug
taper
initi
unless
side
effect
problem
glucocorticoid
dosag
taper
level
approach
mglkg
oral
dosag
azathioprin
dog
mglkg
clinic
respons
achiev
continu
everi
day
month
longer
slow
taper
littl
mglkg
may
achiev
slow
taper
lowest
dose
possibl
decreas
side
effect
expens
therapi
glucocorticoid
given
altern
day
azathioprin
given
switch
chrysotherapi
recommend
highdos
prednison
combin
azathioprin
mglkg
month
mglkg
month
ineffect
anoth
option
continu
increas
azathioprin
dose
complet
blood
count
rel
normal
especi
patient
lymphopen
cat
suscept
azathioprin
toxic
includ
fatal
leukopenia
thrombocytopenia
drug
use
cautious
speci
cyclosporin
cyclosporin
sandimmun
novarti
effect
prevent
human
organ
transplant
reject
see
chap
anim
model
use
similar
excel
resultsp
also
evalu
treatment
immunemedi
skin
diseas
system
use
discuss
chapter
initi
studi
dog
cat
immunolog
dermatos
pemphigu
foliaceu
pemphigu
erythematosu
discoid
lupu
erythematosu
shown
cyclosporin
rare
effect
usual
use
concurr
glucocorticoid
topic
cyclosporin
avail
veterinari
product
ointment
optimmun
scheringplough
use
treat
keratoconjunct
sicca
benefit
may
reflect
vehicl
use
studi
treat
canin
nictitan
plasmacyt
conjunct
show
signific
respons
clinic
symptom
well
reduct
posttreat
plasma
cell
mfiltrat
control
studi
topic
cyclosporin
immunemedi
skin
diseas
publish
howev
other
seen
case
local
diseas
lupu
erythematosu
pemphigu
erythematosu
improv
topic
cyclosporin
ad
treatment
regimen
leflunomid
activ
wide
rang
immun
disord
murin
human
model
antiprohf
effect
celldepend
cellindepend
antibodi
synthesi
inhibit
pyrimidin
synthesi
antagon
action
tumor
necrosi
factor
tnf
use
prednison
cyclosporin
leflunomid
virtual
elimin
allograft
reject
respons
one
metabolit
leflunomid
highli
gastroenterotox
dog
thu
dose
dosag
regimen
must
close
follow
dosag
dog
mglkglday
oral
serum
trough
level
j
lglml
achiev
chrysotherapi
use
gold
therapeut
agent
gold
compound
capabl
modul
mani
phase
immun
inflammatori
respons
exact
mechan
effect
unknown
gold
avail
two
dosag
form
dissimilar
pharmacokinet
oral
compound
auranofin
ridaura
smithklin
beecham
contain
gold
parenter
compound
aurothioglucos
solgan
schere
contain
gold
neither
form
approv
use
dog
cat
distribut
metabol
action
establish
human
laboratori
anim
studi
human
show
oral
form
absorb
attain
blood
level
halflif
small
amount
detect
tissu
skinl
clinic
trial
dog
immunemedi
dermatos
result
oral
gold
equivoc
advers
side
effect
observedl
parenter
form
absorb
halflif
blood
proteinbound
well
distribut
cell
mononuclear
phagocyt
system
liver
spleen
bone
marrow
kidney
adren
gland
much
lower
level
detect
skin
human
gold
may
act
sever
level
inflammatori
immun
respons
auranofin
appear
addit
immunomodul
action
wherea
gold
sodium
thiomal
inhibit
eosinophil
surviv
oral
parenter
gold
inhibit
bacteria
first
compon
complement
epiderm
enzym
may
respons
blister
format
gold
inhibit
phagocytosi
macrophag
gold
also
reduc
releas
inflammatori
mediat
lysosom
enzym
histamin
prostaglandin
inactiv
complement
compon
interfer
immunoglobulinsynthes
cell
inhibit
antigenand
mitogeninduc
tcell
prolifer
suppress
receptor
toxic
effect
worrisom
human
patient
advers
reaction
although
reaction
minor
common
skin
erupt
oral
reaction
proteinuria
bone
marrow
depress
induct
phase
hemogram
urinalysi
check
weekli
monthli
dog
treat
inject
gold
salt
common
side
effect
pain
inject
site
addit
two
dog
experienc
revers
thrombocytopenia
four
dog
experienc
fatal
toxic
epiderm
necrolysi
switch
immedi
azathioprin
aurothioglucos
therapi
pemphigu
foliaceu
may
enhanc
previou
concurr
administr
seen
aurothioglucoserel
erythema
multiform
dog
cat
one
dog
one
cat
manifest
primarili
oral
ulcer
erythema
parenter
gold
aurothioglucos
report
effect
treatment
case
canin
felin
pemphigu
unrespons
glucocorticoid
azathioprin
prednison
combin
therapyp
use
treatment
canin
bullou
pemphigoid
felin
plasma
cell
pododermatitist
although
advers
reaction
develop
late
therapi
suggest
small
test
dose
mg
given
intramuscularli
patient
less
kg
bodi
weight
mg
given
larger
patient
first
week
dosag
increas
mglkg
intramuscularli
weekli
remiss
occur
respons
occur
week
therapi
dosag
increas
remiss
one
dose
given
everi
week
monthli
sever
month
advis
halt
medic
administr
eventu
observ
patient
go
complet
remiss
wherea
anim
maintain
reduc
dosag
two
point
caution
treatment
take
week
full
effect
occur
medicationtyp
glucocorticoidsshould
maintain
need
full
dosag
lag
period
pass
gold
compound
administ
simultan
cytotox
drug
azathioprin
cyclophosphamid
toxic
therebi
enhanc
oral
form
gold
auranofin
use
dog
pemphigu
mglday
littl
success
recommend
mglkg
avail
nonbreak
capsul
addit
oral
form
expens
gold
seldom
firstchoic
drug
pemphigu
patient
usual
start
glucocorticoid
regimen
azathioprin
ad
reduc
steroid
dosag
case
excess
side
effect
azathioprin
prednison
ineffect
gold
logic
choic
may
especi
use
cat
gold
inject
delay
week
discontinu
azathioprin
dapson
dapson
tablet
jacobu
antiinflammatori
antibacteri
chemic
sulfon
inhibit
action
lysosom
enzym
neutrophil
chemotaxi
degranul
mast
cell
synthesi
igg
iga
prostaglandin
activ
altern
complement
pathway
cell
responsesl
antioxid
scaveng
also
inhibit
proteas
inhibit
incorpor
cholin
cell
membran
result
disrupt
phospholipid
suggest
dapson
interfer
myeloperoxidasehalidemedi
toxic
inhibit
neutrophil
chemotaxi
inhibit
ili
stimul
adhes
neutrophil
endotheli
cell
inhibit
adher
neutrophil
antibodi
deposit
skin
inhibit
integrinmedi
neutrophil
adherencef
dapson
use
variou
diseas
character
accumul
neutrophil
case
eosinophilsp
human
efficaci
dermat
herpetiformi
erythema
elevatum
diutinum
errat
effect
wide
varieti
human
skin
diseas
includ
leukocytoclast
vascul
bullou
lupu
erythematosu
bullou
pemphigoid
discoid
lupu
erythematosu
sub
corneal
pustular
dermatosi
linear
iga
bullou
dermatosi
relaps
polychondritisj
case
human
dosag
regimen
start
low
rapidli
build
mglday
dosag
held
respons
occur
gradual
decreas
stop
month
mani
case
relaps
treatment
dapson
also
effect
human
leprosi
case
rheumatoid
arthriti
dog
dapson
use
benefit
case
subcorn
pustular
dermatosi
leukocytoclast
vascul
linear
iga
pustular
dermatosi
pemphigu
foliaceu
erythematosu
dapson
use
first
two
diseas
although
case
control
last
three
diseas
half
case
show
benefit
howev
case
pemphigu
success
treat
immunosuppress
combin
azathioprin
corticosteroid
addit
dapson
permit
lower
dose
corticosteroid
dapson
approv
use
dog
cat
unit
state
report
suggest
dosag
mglkg
dog
oral
week
lesion
clear
reduct
frequenc
administr
other
use
drug
daili
everi
hour
combin
prednison
less
frequent
administr
may
warrant
studi
normal
dog
show
halflif
hour
intraven
administrationp
one
dog
given
approxim
mgl
kg
bioavail
halflif
hour
mainten
dosag
reduc
twice
weekli
even
stop
toxic
somewhat
doserel
potenti
toxic
seriou
induct
mild
anemia
leukopenia
moder
elev
serum
alanin
aminotransferas
level
may
expect
necessit
stop
treatment
anim
remain
clinic
normal
blood
dyscrasia
thrombocytopenia
skin
reaction
hepat
toxic
seriou
appear
rare
patient
monitor
everi
week
induct
therapi
hemogram
platelet
count
blood
urea
nitrogen
determin
urinalysi
serum
alanin
aminotransferas
determin
cat
especi
suscept
dapson
toxic
hemolyt
anemia
variou
neurotox
report
dosag
mglkg
oral
recommend
sulfasalazin
azulfidin
pharmacia
convert
colon
sulfapyridin
antiinflammatori
action
lob
dosag
mglkg
orallyf
lob
dosag
may
reduc
even
chang
everi
day
maintain
clinic
remiss
seriou
side
effect
longterm
administr
product
kerat
sicca
thu
tear
product
check
regularli
one
report
two
case
subcom
pustular
dermatosi
manag
satisfactorili
sulfasalazin
becom
refractori
dapsonel
sulfasalazin
also
use
success
manag
neutrophil
combin
tetracyclin
niacinamid
recommend
treatment
discoid
lupu
erythematosu
pemphigu
erythematosu
dog
report
result
variabl
case
excel
respons
also
effect
case
pemphigu
foliaceu
ad
azathioprin
prednison
regimen
case
vesicular
cutan
lupu
erythematosu
tdiopath
ulcer
dermatosi
colli
shetland
sheepdog
respond
well
tetracyclin
niacinamid
combin
also
use
success
dog
lupoid
onychodystrophi
german
shepherd
dog
metatars
fistula
steril
pannicul
steril
granulomatouspyogranulomat
dermat
vascul
cutan
histiocytosi
see
chap
precis
mechan
action
unknown
howev
tetracyclin
possess
variou
antiinflammatori
immunomodulatori
properti
includ
suppress
vitro
lymphocyt
blastogen
transform
antibodi
product
suppress
vivo
leukocyt
chemotact
respons
inhibit
activ
complement
compon
inhibit
lipas
collagenas
inhibit
prostaglandin
synthesi
niacinamid
shown
block
antigenigeinduc
histamin
releas
vivo
vitro
prevent
degranul
mast
cell
inhibit
phosphodiesteras
decreas
proteas
releasesu
initi
dosag
dog
weigh
kg
mg
tetracyclin
mg
niacinamid
given
respons
favor
dosag
may
decreas
although
studi
report
one
us
ceg
note
combin
may
shown
benefit
use
concurr
vitamin
e
glucocorticoid
also
report
tetracyclin
alon
may
benefici
treat
discoid
lupu
erythematosu
side
effect
uncommon
although
vomit
anorexia
lethargi
diarrhea
report
primarili
due
niacinamid
lll
one
us
ceg
also
saw
two
case
anorexia
increas
liver
enzym
activ
resolv
discontinu
therapi
one
case
tetracyclin
administr
continu
suggest
niacinamid
respons
advers
reaction
sever
antimalari
use
treatment
human
discoid
lupu
erythematosu
dermatomyos
polymorph
light
erupt
solar
urticaria
scleroderm
also
anecdot
report
respons
cutan
leishmaniasi
cutan
cryptococcosi
epidermolysi
bullosa
lymphocyt
skin
infiltrationsu
antimalari
may
futur
use
problem
case
involv
anim
diseas
specif
mode
action
unknown
drug
stabil
lysosom
membran
thu
antiinflammatori
inhibit
protein
synthesi
viral
replic
cellmedi
immun
affect
develop
primari
secondari
antibodi
respons
inhibit
complement
consequ
may
inhibit
format
immun
complex
explain
effect
system
lupu
erythematosu
relat
autoimmun
disord
drug
seldom
use
alon
firstlin
therapi
human
usual
given
salicyl
small
dose
corticosteroid
side
effect
numer
seriou
affect
eye
drug
commonli
use
human
quinacrin
hydrochlorid
atabrin
hydrochlorid
winthrop
chloroquin
aralen
winthrop
hydroxychloroquin
sulfat
plaquenil
sulfat
winthrop
place
veterinari
dermatolog
yet
determin
although
anecdot
report
suggest
antimalari
may
benefici
canin
lupu
erythematosusp
case
report
studi
support
efficaci
report
colchicin
use
treatment
human
leukocytoclast
vascul
epidermolysi
bullosa
acquisita
linear
iga
bullou
dermatosi
dermat
herpetiformi
relaps
polychondritisl
may
futur
use
problem
case
involv
anim
diseas
colchicin
alkaloid
suppress
neutrophil
chemotact
phagocyt
function
via
disrupt
microtubul
assembl
elong
increas
cellular
cyclic
amp
level
inhibit
lysosom
degranul
also
inhibit
immunoglobulin
secret
ill
product
histamin
releas
human
leukocyt
antigen
hla
dr
express
main
side
effect
gastrointestin
earli
clinic
report
dog
involv
use
colchicin
analog
case
eczemat
report
interpret
pemphigu
complex
group
uncommon
autoimmun
diseas
describ
dog
cat
compar
human
diseas
although
similar
mani
signific
differ
exist
disord
vesiculobul
pustular
disord
skin
mucou
membran
character
acantholysi
loss
cohes
keratinocyt
human
least
eight
varieti
pemphigu
wherea
dog
cat
least
five
varietiesp
human
pemphigu
complex
character
histolog
intraepitheli
acantholysi
lead
vesicl
format
lmrnunolog
presenc
autoantibodi
compon
keratinocyt
desmosom
bound
skin
circul
seruml
clinic
lesion
sever
bodi
locat
appear
relat
compon
desmosom
autoantibodi
target
instanc
human
mucos
domin
pemphigu
vulgari
antibodi
desmoglein
iii
pemphigu
foliaceu
produc
antibodi
desmoglein
patient
mucocutan
pemphigu
vulgari
produc
use
neonat
mous
model
inject
antidesmoglein
iii
igg
alon
effici
induc
gross
skin
lesion
wherea
combin
antidesmoglein
iii
antidesmoglein
produc
lesionsp
pemphigu
vulgari
progress
cutan
involv
antidesmoglein
antibodi
produc
possibl
epitop
spread
dog
cat
pemphigu
vulgari
caus
intraepiderm
vesicl
bulla
form
pemphigu
typic
associ
intraepiderm
pustul
major
distinct
human
canin
felin
diseasesv
past
pemphigu
antibodi
readili
demonstr
skin
serum
mani
dog
catsp
human
neg
immunolog
find
rais
seriou
doubt
diagnosi
variant
pemphigu
howev
techniqu
find
serum
autoantibodi
improv
frequenc
detect
increas
two
differ
rais
question
patholog
similar
accuraci
diagnosi
base
clinic
histopatholog
find
human
anim
diseas
part
discrep
also
relat
sensit
techniqu
appear
find
case
detect
serum
autoantibodi
autoantibodi
target
similar
ident
structur
human
diseas
studi
compar
case
without
appropri
immunolog
find
need
determin
whether
multipl
similar
diseas
identif
primarili
relat
sensit
techniqu
use
pemphigu
antigen
heterogen
kd
present
mammalian
avian
skin
identifi
specif
associ
desmosom
componentsp
human
region
variat
exist
express
pemphigu
foliaceu
pemphigu
vulgari
antigen
also
differ
otherp
region
differ
specif
profil
patient
autoantibodi
correl
help
explain
distribut
lesion
clinic
diseas
canin
skin
shown
similar
antigensi
pemphigu
vulgari
pemphigu
foliaceu
antibodi
human
patient
reproduc
respect
clinic
histopatholog
immunopatholog
syndrom
inject
neonat
mice
antibodi
antigen
associ
patholog
howev
pathomechan
blister
format
pemphigu
unknown
though
propos
follow
bind
pemphigu
antibodi
antigen
intern
pemphigu
antibodi
fusion
antibodi
intracellular
lysosom
result
activ
releas
keratinocyt
proteolyt
enzym
plasminogen
activ
anoth
factor
diffus
extracellular
space
convert
plasminogen
plasmin
hydrolyz
adhes
molecul
result
loss
intercellular
cohes
lead
acantholysi
blister
format
within
epidermi
pemphigu
antibodyinduc
acantholysi
depend
complement
inflammatori
cell
experiment
howev
complement
potenti
acantholysi
urokinasetyp
plasminogen
activ
receptor
shown
increas
express
skin
lesion
human
pemphigu
vulgari
pemphigu
foliaceu
studi
shown
plasminogen
activ
activ
correl
lesion
develop
studi
conduct
genet
engin
mous
model
also
suggest
direct
interfer
antibodi
target
creat
similar
lesion
desmoglein
iilnul
mice
treatment
human
pemphigu
vulgari
serum
induc
extens
acantholysi
blister
suggest
autoantibodi
cellsurfac
molecul
desmoglein
desmoglein
iii
induc
pemphigu
vulgari
patient
pemphigu
vulgari
pemphigu
foliaceu
igg
antibodi
precipit
cholinerg
receptorsv
cholinerg
receptor
control
keratinocyt
adhes
motil
inactiv
autoantibodi
may
elicit
cell
signal
caus
desmosom
disassembl
although
keratinocyt
desmosom
cadherin
desmoglein
iii
hold
cell
togeth
desmoglein
illnul
mice
experi
spontan
acantholysi
blister
addit
activ
cholinerg
receptor
prevent
stop
revers
acantholysi
elicit
pemphigu
antibodi
vitro
thu
acantholysi
pemphigu
may
mediat
least
two
complementari
pathogen
pathway
anticholinerg
receptor
autoantibodi
weaken
intercellular
adhes
keratinocyt
via
inactiv
cholinerg
receptormedi
physiolog
control
cadherin
desmoglein
express
andor
function
caus
dyshes
cell
detach
round
acantholysi
autoantibodi
adher
molecul
eg
desmoglein
prevent
format
new
desmosom
ultraviolet
light
irradi
exacerb
acantholysi
induc
antidesmoglein
antidesmoglein
iii
autoantibodi
patient
pemphigu
erythematosu
pemphigu
foliaceu
pemphigu
vulgari
initi
autoantibodi
format
still
unknown
though
viru
spread
insect
vector
suspect
endem
form
pemphigu
foliaceu
fogo
selvagem
south
america
suggest
black
fli
may
play
role
vector
hypothesi
support
epidemiolog
studi
correl
exposur
black
fli
risk
factor
endem
pemphigu
foliaceusr
genet
factor
human
dog
also
appear
import
human
pemphigu
foliaceu
pemphigu
vulgari
hla
associ
popul
may
suscept
pemphigu
vulgari
due
differ
immun
respons
gene
although
demonstr
dog
breed
predisposit
famili
case
shown
factor
thought
involv
pathogenesi
case
pemphigu
drug
provoc
especi
penicillamin
phenylbutazon
ultraviolet
light
emot
upset
drug
chronic
skin
diseas
seem
import
pathogenesi
case
canin
felin
pemphigu
interestingli
druginduc
diseas
human
less
commonli
associ
classic
immunopatholog
find
possibl
human
druginduc
form
similar
anim
pemphigu
commonli
incrimin
drug
highli
reactiv
sulfhydryl
moieti
eg
penicillamin
amid
compon
eg
captopril
penicillin
cephalosporin
diet
implic
caus
pemphigu
humansp
molecular
structur
mani
food
ingredi
similar
known
pemphigusinduc
drug
instanc
thiol
contain
garlic
onion
leek
chive
isothiocyan
mustard
horseradish
turnip
radish
cabbag
cauliflow
brussel
sprout
phenol
mango
cashew
mani
food
addit
tannin
tea
coffe
ginseng
certain
berri
banana
pear
appl
avocado
interestingli
human
fogo
selvagem
live
close
river
mani
contain
high
level
tannin
decompos
leav
veget
matterf
heat
humid
caus
tannin
decomposit
perhap
consumpt
substanc
import
black
fli
owe
thin
characterist
canin
felin
epidermi
intraepiderm
vesicl
bulla
pustul
fragil
transient
thu
clinic
lesion
usual
includ
eros
ulcer
border
epiderm
collarett
pemphigu
complex
uncommon
dog
cat
account
canin
felin
skin
disord
seen
univers
small
anim
gener
variou
form
pemphigu
rel
distinct
clinic
differ
certain
diagnost
featur
howev
appli
whole
group
import
diagnost
aspect
histori
physic
examin
histopatholog
find
detect
pemphigu
antibodi
direct
immunofluoresc
immunohistochem
test
may
also
help
owe
cost
technic
problem
rel
poor
diagnost
sensit
specif
routin
laboratori
test
routin
recommend
perform
howev
pemphigu
variant
show
intercellular
deposit
igg
complement
compon
see
fig
ia
three
seven
dog
pemphigu
foliaceu
igg
subtypesp
occasion
immunoglobulin
class
found
indirect
immunofluoresc
test
infrequ
yield
posit
result
unless
research
laboratori
use
even
result
still
routin
positivep
pemphigu
erythematosu
may
show
deposit
immunoreact
along
basement
membran
zone
addit
intercellular
find
see
fig
ib
microscop
examin
direct
smear
intact
vesicl
pustul
recent
eros
often
reveal
numer
nondegener
neutrophil
occasion
numer
eosinophil
numer
acantholyt
keratinocyt
one
two
acantholyt
keratinocyt
may
visibl
occasion
highpow
microscop
field
microscop
examin
suppur
condit
cell
present
cluster
larg
number
sever
microscop
field
strongli
suggest
pemphigu
skin
biopsi
may
diagnost
strongli
support
pemphigu
intact
vesicl
bulla
pustul
essenti
lesion
fragil
transient
may
necessari
hospit
anim
care
scrutin
hour
presenc
primari
lesion
bullou
lesion
observ
biopsi
must
perform
immedi
multipl
biopsi
serial
section
greatli
increas
chanc
demonstr
diagnost
histolog
chang
electronmicroscop
examin
pemphigu
lesion
suggest
dissolut
intercellular
cement
substanc
initi
patholog
chang
follow
retract
tonofila
disappear
desmosom
acantholysi
result
routin
laboratori
determin
hemogram
serum
chemistri
urinalysi
serum
protein
electrophoresi
nondiagnost
often
reveal
mild
moder
leukocytosi
neutrophilia
mild
nonregen
anemia
mild
hypoalbuminemia
mild
moder
elev
globulin
prognosi
canin
pemphigu
appear
vari
form
sever
diseas
natur
cours
untreat
case
unclear
veterinarian
long
recogn
refractori
mucocutan
eros
ulcer
disord
sever
exfoli
dermatos
result
death
euthanasia
affect
dog
cat
retrospect
mani
dog
cat
may
pemphigu
vulgari
pemphigu
foliaceu
basi
small
number
case
document
veterinari
literatur
pemphigu
vulgari
appear
sever
diseas
often
fatal
even
treatment
mani
anim
fail
respond
euthan
pemphigu
foliaceu
less
sever
without
therapi
may
fatal
pemphigu
erythematosu
panepiderm
pustular
pemphigu
vegetan
usual
benign
disord
rare
produc
system
sign
readili
respond
treatmentp
prognosi
treatment
differ
form
vari
import
make
specif
diagnosi
suspect
druginduc
case
pemphigu
may
requir
prolong
therapi
seem
like
allow
treatment
perman
discontinu
remiss
maintain
month
case
paraneoplast
pemphigu
describ
allow
comment
though
condit
carri
poor
prognosi
human
therapi
canin
felin
pemphigu
often
difficult
requir
larg
dose
system
glucocorticoid
without
potent
immunomodul
drug
side
effect
drug
common
vari
mild
sever
close
physic
hematolog
monitor
patient
critic
addit
therapi
must
usual
maintain
prolong
period
life
thu
therapeut
regimen
must
individu
patient
owner
educ
essenti
larg
dose
glucocorticoid
mglkg
prednison
oral
dog
mglkg
prednison
cat
induc
remiss
patient
howev
sever
glucocorticoid
side
effect
inabl
achiev
safe
alternateday
mainten
regimen
render
drug
unaccept
least
case
referr
dermatolog
practic
case
adequ
control
glucocorticoid
alon
glucocorticoid
ineffect
undesir
immunomodul
drug
use
attempt
reduc
dosag
elimin
need
glucocorticoid
azathioprin
often
drug
choic
situat
dog
azathioprin
use
either
cautious
cat
even
small
dose
mglkg
oral
may
produc
fatal
leukopenia
thrombocytopentap
chlorambucil
effect
dog
cat
prefer
treatment
cat
chrysotherapi
use
gold
salt
also
use
especi
cat
case
control
azathioprin
prednison
pv
anim
signific
nasal
depigment
occur
photodermat
becom
aggrav
factor
photoprotect
import
therapeut
avoid
sunlight
pm
help
use
sunscreen
contain
paraaminobenzo
acid
high
sunprotect
factor
valu
spf
greater
mandatori
sunscreen
appli
hour
sun
exposur
anticip
reappli
everi
hour
drug
may
use
individu
case
includ
dapson
great
caution
cat
mglkg
vitamin
e
tetracyclineniacinamid
product
contain
fatti
acid
see
chap
use
pentoxifyllin
inhibit
autoimmun
diabet
mellitu
mice
suggest
concurr
use
may
warrant
unrespons
case
pemphlgusv
given
recent
interest
dietinduc
pemphigu
human
perhap
veterinarian
consid
restrict
diet
trial
pay
particular
attent
thiol
isothiocyan
phenol
tannin
dog
cat
refractori
case
pemphigu
one
us
dw
receiv
anecdot
report
success
diet
modif
dog
pemphigu
vulgari
report
dog
cat
appear
second
rarest
form
pemphigusp
gener
specialti
dermatolog
practic
account
less
case
human
dog
major
pemphigu
vulgari
antigen
desmoglein
iii
glycoprotein
cadherin
group
adhes
moleculesl
sever
case
also
cutan
involv
antibodi
desmoglein
also
present
human
pathogenici
exact
antigen
felin
specif
identtfledp
age
breed
sex
predilect
report
pemphigu
vulgari
vesiculobul
eros
ulcer
disord
may
affect
oral
caviti
mucocutan
junction
lip
nostril
eyelid
prepuc
vulva
anu
skin
combin
thereof
fig
affect
anim
oral
caviti
lesion
time
diagnosi
oral
caviti
involv
initi
sign
anim
often
present
halitosi
excess
saliv
cutan
lesion
occur
commonli
axilla
groin
nikolski
sign
may
present
clawb
may
involv
result
ulcer
paronychia
onychomadesi
may
present
sign
pemphigu
vulgari
limit
skin
rare
pruritu
pain
variabl
secondari
bacteri
pyoderma
lymphadenopathi
may
present
sever
affect
anim
may
anorect
depress
febril
differenti
diagnosi
pemphigu
vulgari
includ
bullou
pemphigoid
epidermolysi
bullosa
acquisita
linear
iga
bullou
dermatosi
system
lupu
erythematosu
erythema
multiform
toxic
epiderm
necrolysi
drug
reaction
candidiasi
idiopath
ulcer
dermat
vesicular
cutan
lupu
erythematosu
colli
shetland
sheepdog
epitheliotrop
lymphoma
numer
caus
canin
felin
ulcer
stomat
definit
diagnosi
pemphigu
vulgari
base
histori
physic
examin
direct
smear
biopsi
immunofluoresc
immunohistochem
test
demonstr
antigen
target
desmoglein
iii
pemphigu
vulgari
character
histolog
suprabasilar
acantholysi
result
cleft
vesicl
format
fig
basal
epiderm
cell
remain
attach
basement
membran
zone
like
row
tombston
fig
dermal
inflammatori
reaction
may
scant
perivascular
cellpoor
promin
interstiti
lichenoid
cellrich
pemphigu
vulgari
appear
carri
poorest
prognosi
group
report
eight
canin
case
two
patient
kept
remiss
year
three
die
euthan
three
lost
followupp
suggest
agre
case
initi
treat
aggress
highdos
prednison
azathioprin
without
treatment
disord
may
tend
difficult
form
put
keep
remiss
system
glucocorticoid
alon
combin
azathioprin
initi
treatment
choic
dog
wherea
system
glucocorticoid
alon
combin
chlorambucil
prefer
cat
combin
therapi
usual
requir
heparin
iukg
subcutan
shown
least
temporari
benefici
effect
one
medic
resist
case
pemphigu
pemphigu
vegetan
report
dog
consid
extrem
rare
suggest
case
repres
newli
propos
variant
panepiderm
pustular
pemphigu
though
clinic
featur
differ
age
breed
sex
predilect
appar
pemphigu
vegetan
vesiculopustular
disord
evolv
verruc
veget
papillomat
prolifer
ooz
stud
pustul
see
fig
f
nikolski
sign
may
present
pruritu
pain
variabl
dog
usual
otherwis
healthi
pemphigu
vegetan
thought
repres
benign
abort
form
pemphigu
vulgari
anim
resist
diseas
differenti
diagnosi
pemphigu
vegetan
includ
bacteri
fungal
granuloma
benign
famili
chronic
pemphigu
cutan
neoplasia
especi
lyrnphoreticular
neoplasia
mast
cell
tumor
definit
diagnosi
pemphigu
vegetan
base
histori
physic
examin
direct
smear
biopsi
immunofluoresc
immunohistochem
test
pemphigu
vegetan
character
histopatholog
papil
epiderm
hyperplasia
papillomatosi
intraepiderm
microabscess
predominantli
contain
eosinophil
acantholyt
keratinocyt
fig
case
pemphigu
vegetan
describ
specif
recommend
made
initi
system
glucocorticoid
would
indic
one
report
three
case
mention
respond
readili
taper
dosag
glucocorticoid
glucocorticoid
effect
azathioprin
would
ad
report
case
put
pemphigu
vegetan
describedv
us
howev
mani
dog
case
appear
deep
pemphigu
erythematosu
pemphigu
foliaceu
diagnosi
pemphigu
vegetan
base
histopatholog
presenc
pustul
epidermi
follicular
infundibula
dunstanv
refer
group
pemphigu
vegetanserythematosu
consid
entiti
similar
human
pemphigu
vegetan
hallopeau
type
other
propos
name
panepiderm
pustular
pemphigu
one
case
evalu
immunopatholog
autoantibodi
desmoglein
similar
pemphigu
foliaceusl
base
clinic
find
limit
immunopatholog
studi
entiti
distinctli
character
still
believ
dog
simpli
pemphigu
foliaceu
pemphigu
erythematosu
pemphigu
foliaceu
common
form
pemphigu
perhap
common
immunemedi
dermatosi
dog
cat
report
account
high
case
dermatolog
referr
practic
low
hospit
canin
popul
major
pemphigu
foliaceu
antigen
desmoglein
glycoprotein
cadherin
group
adhes
molecul
antigen
target
autoantibodi
dog
age
sex
predilect
report
dog
akita
chow
chow
dachshund
beard
colli
newfoundland
doberman
pinscher
finnish
spitz
schipperk
may
predisposedp
mean
age
onset
year
affect
dog
experienc
diseas
year
less
pemphigu
foliaceu
character
pustular
dermat
see
fig
import
differenti
human
pemphigu
foliaceu
start
erythema
vesicl
may
progress
pustul
canin
felin
pemphigu
foliaceu
vesicular
phaseit
pustular
crust
diseas
three
form
pemphigu
foliaceu
appear
exist
canin
first
spontan
canin
pemphigu
foliaceu
akita
chow
chow
may
prone
form
diseas
develop
dog
previou
histori
skin
diseas
drug
exposur
second
form
druginduc
pemphigu
foliaceu
may
common
labrador
retriev
doberman
pinscher
druginduc
pemphigu
becom
frequent
recogn
sever
case
associ
administr
trimethoprtmsulfonamid
third
form
occur
dog
histori
chronic
skin
diseas
dog
often
one
year
usual
prurit
allerg
skin
diseas
suddenli
experi
sever
diseas
new
featur
end
diagnos
pemphigu
foliaceu
dog
chronic
diseaseassoci
pemphigu
foliaceu
often
expos
multipl
drug
theirdiseas
may
occasion
druginduc
though
causeandeffect
relationship
obviou
erupt
go
away
drug
stop
season
environment
risk
factor
found
studi
pemphigu
foliaceu
dog
cat
pemphigu
foliaceu
usual
begin
face
ear
fig
commonli
involv
feet
clawb
footpad
villou
hyperkeratosi
hard
pad
see
fig
e
groin
becom
multifoc
gener
see
fig
within
month
mani
anim
earli
lesion
consist
erythemat
macul
rapidli
progress
pustular
phase
see
fig
end
dri
yellow
honeycolor
brown
crust
see
fig
usual
scale
alopecia
eros
border
epiderm
collarett
nikolski
sign
may
present
mucocutan
orient
uncommon
oral
caviti
involv
rare
dog
cat
pemphigu
foliaceu
present
footpad
lesion
may
lameu
paronychia
involv
nippl
common
cat
variou
claw
abnorm
onychodystrophi
onychorrhexi
onychogryposi
occasion
occur
dog
nasal
depigment
common
may
result
photodermat
see
follow
discuss
pemphigu
erythematosu
pruritu
pain
variabl
secondari
bacteri
pyoderma
peripher
lymphadenopathi
may
present
sever
affect
anim
may
anorect
depress
febril
diseas
commonli
waxingwan
cours
may
hour
day
numer
new
pustul
form
follow
day
week
crust
new
lesion
found
differenti
diagnosi
pemphigu
foliaceu
includ
bacteri
follicul
dermatophytosi
demodicosi
dermatophilosi
seborrh
skin
diseas
benign
famili
chronic
pemphigu
pemphigu
erythematosu
discoid
system
lupu
erythematosu
dermatomyos
cutan
advers
drug
reaction
dermatophytosi
mimic
histopatholog
well
clinic
find
see
chap
addit
pemphigu
foliaceu
could
confus
subcorn
pustular
dermatosi
steril
eosinophil
pustulosi
linear
iga
pustular
dermatosi
necrolyt
migratori
erythema
leishmaniasi
zincrespons
dermat
definit
diagnosi
pemphigu
foliaceu
base
histori
physic
examin
direct
smear
skin
biopsi
immunofluoresc
immunohistochem
test
demonstr
antigen
target
desmoglein
pemphigu
foliaceu
character
histolog
intragranular
sub
corneal
acantholysi
result
cleft
vesicl
pustul
format
fig
within
vesicl
pustul
cell
stratum
granulosum
may
attach
overli
stratum
corneum
granular
cell
clingen
fig
b
either
neutrophil
eosinophil
may
predomin
within
vesicl
pustul
help
histopatholog
find
canin
felin
pemphigu
foliaceu
eosinophil
exocytosi
microabscess
format
within
epidermi
follicular
outer
root
sheath
frequent
involv
follicular
outer
root
sheath
acantholyt
pustular
process
acantholyt
dyskeratot
granular
epiderm
cell
grain
surfac
eros
fig
initi
treatment
choic
pemphigu
foliaceu
depend
clinic
present
milder
local
case
may
treat
topic
steroid
wherea
extens
diseas
usual
treat
oral
prednison
induct
dose
maintain
diseas
inact
though
alopecia
residu
crust
may
present
induct
dosag
taper
alternateday
regimen
cat
patient
fail
respond
prednison
may
respond
dexamethason
mglkg
triamcinolon
mglkg
safe
maintain
administr
either
product
everi
second
third
day
suggest
oral
triamcinolon
may
superior
prednison
prednisolon
howev
need
evaluatedp
oral
glucocorticoid
ineffect
unsatisfactori
least
case
dog
next
common
treatment
addit
azathioprin
combin
immunosuppress
therapi
cat
chlorambucil
chrysotherapi
use
dog
respond
azathioprin
glucocorticoid
gold
salt
inject
may
warrant
wait
week
discontinu
azathioprin
state
patient
canin
felin
pemphigu
foliaceu
fail
respond
treatment
euthanizedp
pemphigu
erythematosu
thought
repres
benign
form
pemphigu
foliaceu
worker
also
suggest
may
repres
crossov
syndrom
pemphigu
lupu
erythematosu
histopatholog
immunopatholog
find
also
suggest
mild
form
pemphigu
foliaceu
antigen
target
definit
identifi
human
dog
though
human
believ
similar
pemphigu
foliaceu
pemphigu
erythematosu
report
dog
cat
age
sex
predilect
known
dog
colli
german
shepherd
may
predispos
diseas
consid
photoaggrav
case
similar
canin
discoid
lupu
erythematosu
confirm
studi
demonstr
vivo
vitro
sensit
uvb
pemphigu
erythematosu
character
erythemat
pustular
dermat
face
ear
see
fig
primari
lesion
transient
dog
cat
typic
present
ooz
crust
scale
alopecia
eros
border
epiderm
collarett
nikolski
sign
infrequ
present
pruritu
pain
variabl
diseas
involv
often
limit
facialnas
region
nose
frequent
becom
depig
whereupon
photodermat
becom
aggrav
factor
see
nasal
region
primarili
involv
condit
often
wors
sunni
weather
dog
may
misdiagnos
nasal
solar
dermat
colli
nose
often
depigment
earli
sign
pemphigu
erythematosu
contrast
pemphigu
foliaceu
wherein
depigment
come
later
addit
crust
often
milder
occur
pemphigu
foliaceu
oral
caviti
involv
report
affect
anim
usual
otherwis
healthi
occasion
anim
isol
skin
lesion
distant
face
ear
paw
genitalia
differenti
diagnosi
pemphigu
erythematosu
includ
bacteri
follicul
dermatophytosi
demodicosi
benign
famili
chronic
pemphigu
facial
pemphigu
foliaceu
discoid
system
lupu
erythematosu
dermatomyos
drug
reaction
leishmaniasi
zincrespons
dermat
definit
diagnosi
pemphigu
erythematosu
base
histori
physic
examin
direct
smear
skin
biopsi
immunofluoresc
immunohistochem
test
pemphigu
erythematosu
histolog
ident
pemphigu
foliaceu
except
often
lichenoid
cellular
infiltr
mononuclear
cell
plasma
cell
neutrophil
eosinophil
fig
immunopatholog
case
may
low
posit
antinuclear
antibodi
titer
basement
membran
immunoglobulin
deposit
initi
therapeut
option
pemphigu
erythematosu
differ
immunemedi
diseas
import
reason
tri
establish
definit
diagnosi
rather
diagnosi
pemphigu
pemphigu
erythematosu
may
initi
treat
sun
avoid
topic
glucocorticoid
dog
combin
tetracyclin
niacinamid
effect
case
combin
effect
vitamin
e
short
cours
system
glucocorticoid
may
ad
regimen
remiss
initi
therapeut
protocol
may
effect
keep
diseas
remiss
topic
cyclosporin
also
help
case
form
pemphigu
first
character
human
recent
describ
dog
diagnost
criteria
establish
human
includ
sever
oral
ulcer
polymorph
skin
erupt
histolog
includ
intraepitheli
acantholysi
keratinocyt
apoptosi
vacuolar
interfac
chang
direct
immunofluoresc
test
find
includ
intercellular
deposit
igg
within
epithelium
granular
pattern
along
basement
membran
zone
indirect
immunofluoresc
find
includ
igg
deposit
intercellular
space
monkey
esophagu
rodent
urinari
bladderf
immunofluoresc
find
rodent
urinari
bladder
specif
sensit
thu
falseposit
falseneg
result
occur
immunoprecipit
studi
need
confirm
diagnosi
identifi
characterist
antigen
complex
desmoplakin
kd
ii
kd
bullou
pemphigoid
antigen
kd
envoplakin
kd
periplakin
kd
desmoglein
iii
kd
unidentifi
kd
transmembran
antigen
antibodi
human
patient
reproduc
cutan
lesion
inject
newborn
micep
pathogenesi
paraneoplast
pemphigu
unknown
hypothes
antitumor
immun
respons
crossreact
normal
epitheli
protein
perhap
associ
anomal
express
desmosom
andor
desmoplakin
neoplasm
andor
dysregul
cytokin
product
eg
neoplast
cell
autoantibodi
desmoglein
iii
protein
probabl
initi
acantholysi
cell
membran
damag
result
autoantibodi
format
desmoplakin
antidesmoplakin
antibodi
enter
keratinocyt
bind
target
autoantigen
epitopespread
phenomenon
canin
case
shown
three
serum
autoantibodi
import
human
paraneoplast
pemphigu
antibodi
recogn
protein
best
document
canin
case
concurr
lymphomar
two
case
pemphigu
foliaceu
suspect
paraneoplast
pemphigu
one
associ
sertoli
cell
tumor
associ
mammari
carcinomav
human
paraneoplast
pemphigu
usual
associ
malign
especi
lymphoma
tabl
unless
associ
neoplasm
cure
immunosuppress
therapi
effect
classif
autoimmun
blister
diseas
base
antigen
target
pathogen
autoantibodi
autoimmun
subepiderm
bullou
diseas
repres
differ
nosolog
entiti
studi
conduct
olivri
colleagu
demonstr
canin
subepiderm
bullou
diseas
includ
bullou
pemphigoid
autoantibodi
bullou
pemphigoid
antigen
type
xvii
collagen
epidermolysi
bullosa
acquisita
autoantibodi
type
vii
collagen
bullou
system
lupu
erythematosu
igg
autoantibodi
noncollagen
aminoterminu
type
vii
collagen
linear
iga
bullou
dermatosi
iga
igg
autoantibodi
extracellular
portion
bullou
pemphigoid
antigen
intracellular
transmembran
domain
remov
proteolysi
mucou
membran
pemphigold
autoantibodi
antigenposs
cterminu
bullou
pemphigoid
antigen
lower
lamina
lucida
entiti
similar
clinic
histopatholog
routin
immunofluoresc
immunohistochem
test
howev
differ
diseas
studi
larger
number
case
may
reveal
import
prognost
therapeut
differ
use
saltsplit
skin
substrat
indirect
immunofluoresc
test
practic
contribut
studi
autoimmun
subepiderm
bullou
diseas
lmolar
solut
nacl
split
skin
lamina
lucida
allow
recognit
autoantibodi
bind
roof
epiderm
floor
dermal
combin
side
split
bullou
pemphigoid
rare
autoimmun
vesiculobul
ulcer
disord
skin
oral
mucosa
report
dog
cat
humansi
report
account
canin
dermatolog
case
howev
note
major
report
case
diagnos
basi
clinic
histopatholog
immunopatholog
find
basi
specif
antigen
target
like
case
true
bullou
pemphigoid
determin
presenc
autoantibodi
specif
bullou
pemphigoid
antigen
olivri
studi
immunopatholog
antigen
target
dog
subepiderm
blister
diseas
true
bullou
pemphigoid
suggest
diseas
even
rarer
previous
thought
bullou
pemphigoid
character
histolog
subepiderm
vesicl
format
immunologlc
presenc
one
two
autoantibodi
antigen
basal
cell
hemidesmosom
skin
mucosav
bullou
pemphigoid
antigen
present
mammalian
avian
skin
associ
hemidesmosom
lamina
lucida
basement
first
antigen
bullou
pemphigoid
antigen
bpag
intracellular
antigen
homolog
desmoplakin
serum
antibodi
antigen
yet
describ
anim
second
bullou
pemphigoid
antigen
bpag
also
call
collagen
xvii
hemidesmosom
transmembran
moleculel
human
circul
ige
autoantibodi
major
immunoglobulin
preferenti
target
two
distinct
epitop
level
autoantibodi
parallel
diseas
canin
felin
case
bullou
pemphigoid
exhibit
antibodi
latter
moleculep
caus
antibodi
product
still
unknown
genet
factor
determin
human
dog
propos
pathomechan
blister
format
bullou
pemphigoid
follow
bind
complementfix
pemphigoid
antibodi
antigen
hemidesmosom
complement
fixat
activ
activ
mast
cell
releas
chemotact
cytokin
chemoattract
neutrophil
eosinophil
releas
proteolyt
enzym
infiltr
leukocyt
disrupt
dermaepiderm
cohes
result
dermaepiderm
separ
vesicl
formationf
human
elev
concentr
eosinophil
cation
protein
major
basic
protein
neutrophilderiv
myeloperoxidas
elastas
detect
blister
fluid
serum
patient
bullou
pemphigoid
suggest
releas
substanc
activ
granulocyt
may
import
pathogenesi
blister
formationf
eosinophilderiv
enzym
gelatinas
may
involv
cleav
type
xvii
collagen
human
pemphigoid
antibodi
inject
rabbit
cornea
guinea
pig
skin
local
produc
clinic
histolog
immunopatholog
featur
bullou
pemphigoid
factor
thought
involv
pathogenesi
case
bullou
pemphigoid
drug
provoc
especi
sulfonamid
penicillin
furosemid
ultraviolet
light
bullou
pemphigoidlik
drug
erupt
report
dog
though
exact
antigen
target
determin
case
may
true
bullou
pemphigoid
clinic
variant
occur
human
differenti
proceed
base
advanc
method
detect
target
antigen
past
confus
overlap
variant
cicatrici
pemphigoid
herp
gestationi
share
least
partial
target
antigen
note
bullou
pemphigoidar
begin
work
also
case
canin
wherein
olivri
group
recogn
mucou
membran
pemphigoid
diseas
known
cicatrici
pemphigoid
human
still
name
prefer
investigatorsp
mucou
membran
pemphigoid
one
common
form
autoimmun
basement
membran
zone
diseas
dog
phenotyp
distinct
yet
immunolog
heterogen
human
six
case
mucou
membran
pemphigoid
recogn
dog
four
exhibit
antibodi
domain
one
antibodi
cterminu
bullou
pemphigoid
rare
dog
account
canin
skin
disord
one
univers
small
anim
clinic
canin
dermatolog
case
canin
bullou
pemphigoid
report
age
sex
predilect
although
colli
perhap
doberman
pinscher
appear
predispos
diseas
colli
shelti
must
separ
socal
ulcer
dermatosi
colli
shetland
sheepdog
probabl
vesicular
cutan
lupu
erythematosuslp
bullou
pemphigoid
vesiculobul
ulcer
disord
may
affect
oral
caviti
mucocutan
junction
skin
combin
thereof
fig
b
affect
dog
oral
caviti
lesion
time
diagnosi
olivri
confirm
case
canin
bullou
pemphigoid
one
third
exhibit
oral
involv
contrast
case
canin
mucou
membran
pemphigoid
exhibit
consist
mucos
involv
minim
skin
lesionsl
oral
caviti
involv
recogn
either
time
cutan
sign
rare
initi
event
cutan
lesion
occur
commonli
axilla
groin
also
common
site
vesicular
cutan
lupu
erythematosu
colli
shetland
sheepdog
ulcer
paronychia
onychomadesi
footpad
ulcer
may
occur
insidi
chronic
clinic
benign
form
cutan
bullou
pemphigoid
recogn
dog
lesion
confin
axilla
groin
isol
mucocutan
area
anu
prepucef
case
bullou
pemphigoid
may
sever
clinic
indistinguish
pemphigu
vulgari
subepiderm
blister
diseas
true
bullou
pemphigoid
vesicl
bulla
less
fragil
transient
occur
vesicular
cutan
lupu
erythematosu
colli
sheepdogsl
contrast
flaccid
blister
pemphigu
vulgari
blister
bullou
pemphigoid
tens
presenc
intact
vesicl
bulla
suggest
subepiderm
bullou
diseas
studi
hope
abl
better
clinic
differenti
diseas
vesicl
bulla
ruptur
clinician
see
ulcer
border
epitheli
collarett
pseudonikolski
sign
may
present
pruritu
pain
variabl
secondari
bacteri
pyoderma
common
sever
affect
dog
may
anorect
depress
febril
may
die
fluid
electrolyt
protein
imbal
septicemia
result
routin
laboratori
determin
hemogram
serum
chemistri
urinalysi
serum
protein
electrophoresi
nonspecif
often
reveal
mild
moder
leukocytosi
neutrophilia
mild
nonregen
anemia
mild
hypoalbuminemia
mild
moder
elev
peripher
eosinophilia
rare
differenti
diagnosi
includ
pemphigu
vulgari
system
lupu
erythematosu
epidermolysi
bullosa
acquisita
linear
iga
bullou
dermatosi
erythema
multiform
toxic
epiderm
necrolysi
idiopath
ulcer
dermatosi
vesicular
cutan
lupu
erythematosu
colli
shetland
sheepdog
drug
reaction
epitheliotrop
lymphoma
candidiasi
numer
caus
canin
ulcer
stomat
definit
diagnosi
bullou
pemphigoid
base
histori
physic
examin
skin
mucos
biopsi
demonstr
basement
membran
fix
autoantibodi
circul
antibodi
target
bullou
pemphigoid
antigen
microscop
examin
direct
smear
intact
vesicl
bulla
recent
ulcer
reveal
acantholyt
keratinocyt
bullou
pemphigoid
character
histolog
subepiderm
cleft
vesicl
format
fig
acantholysi
occur
inflammatori
infiltr
vari
mild
perivascular
mark
lichenoid
fig
tissu
eosinophilia
common
canin
bullou
pemphigoid
contrast
case
mucou
membran
pemphigoid
noninflammatori
blister
epidermolysi
bullosa
acquisita
case
neutrophilrich
vesiclesp
felin
bullou
pemphigoid
eosinophil
subepiderm
vacuolar
alter
subepiderm
bubbl
suggest
earliest
prevesicl
histopatholog
find
olivri
think
first
lesion
canin
bullou
pemphigoid
might
eosinophil
degranul
basement
membran
zone
fig
electronmicroscop
examin
pemphigoid
lesion
reveal
follow
featur
smudg
thicken
interrupt
basement
membran
zone
fragment
disappear
anchor
fibril
anchor
filament
hemidesmosom
basal
cell
degener
separ
occur
within
lamina
lucidaf
direct
immunofluoresc
immunohistochem
test
reveal
linear
deposit
immunoglobulin
usual
complement
basement
membran
zone
skin
mucosa
patient
see
fig
howev
specif
bullou
pemphigoid
complement
compon
commonli
demonstr
immunoreact
presenc
igg
expectedp
would
appear
import
test
class
immunoglobulin
dog
result
posit
igm
iga
though
light
recent
studi
case
may
truli
bullou
pemphigoid
also
import
sampl
intact
vesicl
bulla
well
perilesion
tissu
indirect
immunofluoresc
test
frequent
yield
neg
result
past
though
definit
diagnosi
includ
demonstr
circul
igg
autoantibodi
bullou
pemphigoid
antigen
one
studi
igg
subtyp
predominantli
natur
cours
untreat
case
unclear
veterinarian
long
recogn
refractori
mucocutan
ulcer
disord
result
death
euthanasia
affect
dog
retrospect
dog
may
bullou
pemphigoid
basi
small
number
case
document
veterinari
literatur
canin
bullou
pemphigoid
usual
sever
diseas
prognosi
true
bullou
pemphigoid
yet
establish
appear
local
benign
diseas
epidermolysi
bullosa
acquisitap
extens
case
may
fatal
unless
treat
therapi
canin
bullou
pemphigoid
may
difficult
requir
larg
dose
system
glucocorticoid
without
potent
immunomodul
drug
one
studi
nine
dog
subepiderm
blister
diseas
believ
bullou
pemphigoidl
follow
observ
made
mglkg
prednisolon
given
oral
ineffect
control
diseas
mglkg
prednisolon
given
oral
q
effect
control
diseas
two
nine
dog
requir
larger
dose
euthan
howev
unaccept
side
effect
anoth
two
die
day
therapi
acut
pancreat
thu
system
glucocorticoid
unsatisfactori
treatment
four
nine
dog
suspect
bullou
pemphigoid
case
experi
usual
requir
combin
immunosuppress
agent
one
case
seen
geg
even
requir
glucocorticoid
azathioprin
chlorambucil
kept
remiss
therapi
usual
must
maintain
prolong
period
life
thu
therapeut
regimen
must
individu
patient
owner
educ
essenti
mild
case
canin
bullou
pemphigoid
may
success
manag
topic
glucocorticoid
rel
low
dose
system
glucocorticoid
mgkgday
prednisolon
prednison
oral
induct
therapi
may
occasion
even
termin
tetracyclin
erythromycin
report
benefici
treatment
bullou
pemphigoid
humansl
thought
benefit
deriv
drug
relat
abil
inhibit
neutrophil
chemotaxi
random
migrat
increas
dermoepiderm
cohes
inhibit
proteas
might
involv
blister
format
cutan
lesion
bullou
pemphigoid
human
induc
exposur
ultraviolet
light
canin
bullou
pemphigoid
may
worsen
exposur
ultraviolet
light
may
prudent
avoid
direct
exposur
sunlight
pm
limit
number
identifi
case
true
canin
bullou
pemphigoid
photosensittvel
definit
diagnosi
made
sun
avoid
still
recommend
epidermolysi
bullosa
acquisita
subepiderm
blister
diseas
thought
one
common
caus
autoimmun
subepiderm
blister
dog
case
human
acquir
autoimmun
diseas
clinic
similar
childhood
form
epidermolysi
bullosah
nameeven
though
hereditari
diseas
typic
found
childrenl
character
chronic
develop
subepiderm
blister
may
induc
trauma
fragil
skin
human
epiderm
separ
similar
bullou
pemphigoid
even
direct
immunofluoresc
test
find
similarl
immunoelectron
microscopi
reveal
antibodi
deposit
locat
anchor
fibril
separ
diseas
bullou
pemphigoid
subsequ
studi
shown
autoantibodi
target
type
vii
collagen
within
anchor
fibril
basement
membran
zonel
case
epidermolysi
bullosa
acquisita
describ
lyearold
intact
male
great
dane
experienc
acut
onset
rapid
progress
skin
lesionsl
gener
urticaria
vesicul
cutan
slough
result
ulcer
ulcer
pronounc
oral
caviti
fig
footpad
dog
also
febril
letharg
treatment
prednison
mglkglday
antibiot
dapson
satisfactori
euthanasia
perform
owner
request
histopatholog
collagen
iv
stain
reveal
subepiderm
vesicl
occur
sublamina
densa
fig
mild
bandlik
infiltr
neutrophil
lymphocyt
visibl
base
subepiderm
vesicl
sever
lesion
neutrophil
microabscess
visibl
superfici
dermi
direct
immunofluoresc
test
reveal
igg
igm
iga
basement
membran
zone
indirect
immunofluoresc
test
igg
iga
basement
membran
zone
dog
lip
tongu
monkey
esophagu
indirect
protein
immunogold
electron
microscopi
western
immunoblot
recombin
collagen
viinci
enzymelink
immunosorb
assay
elisa
use
confirm
autoantibodi
target
collagen
vii
anchor
fibril
olivri
recogn
four
case
four
five
dog
exhibit
gener
phenotyp
respond
treatmentl
one
dog
local
variant
predominantli
head
region
respond
complet
prednison
mglkglday
thu
resembl
brunstingperri
epidermolysi
bullosa
acquisita
humansp
spay
femal
mongrel
dog
present
vesicl
eros
ulcer
crust
lip
pinna
axilla
sternum
groin
extrem
footpad
histolog
examin
reveal
mix
inflammatori
hemorrhag
subepiderm
vesicl
circul
iga
igg
autoantibodi
target
linear
iga
bullou
dermatosi
antigen
ladi
upper
lamina
lucida
lyearold
intact
male
australian
shepherd
present
vesicl
eros
crust
periorbit
perinas
pinnal
skin
well
oral
mucosa
histolog
examin
reveal
larg
subepiderm
vesicl
focal
neutrophil
subepiderm
microabscess
circul
igg
autoantibodi
target
antigen
lower
lamina
lucida
lupu
erythematosu
term
encompass
group
diseas
differ
clinic
syndrom
share
similar
underli
autoimmun
processs
appropri
terminolog
classif
syndrom
case
disord
led
regul
cell
prolifer
downregul
mark
decreas
protein
promot
cell
surviv
inhibit
apoptosi
hypothes
basal
keratinocyt
damag
antibodydepend
cellular
cytotox
becom
hyperprolif
thu
express
induc
express
tum
downregul
activ
apoptot
pathway
epidermi
system
lupu
erythematosu
sever
form
lupu
diseas
involv
cutan
lesion
may
present
wide
array
clinic
symptom
reflect
multipl
organ
tissu
damag
etiolog
system
lupu
erythematosu
appear
multifactori
genet
predilect
immunolog
disord
cell
defici
b
cell
hyperact
defici
complement
compon
viral
infect
hormon
ultraviolet
light
modul
play
role
ib
b
lymphocyt
hyperact
result
plethora
autoantibodi
form
numer
bodi
constitu
wellstudi
ana
found
case
report
studi
antibodi
util
newer
techniqu
immunoblot
immunoprecipit
reveal
number
nuclear
compon
target
includ
doublestrand
dna
histon
extract
nuclear
antigen
latter
may
import
dog
includ
group
ribonuclear
protein
rnp
small
nuclear
rnp
complex
snrnp
heterogen
nuclear
rnp
hnrnp
studi
dog
system
lupu
show
activ
phase
diseas
mark
lymphopenia
though
affect
cell
sever
involv
cellsp
result
alter
increas
ratio
mean
diseas
mean
normal
decreas
lymphocyt
directli
relat
diseas
sever
increas
cell
associ
good
respons
therapi
addit
percentag
activ
phase
cell
increas
success
treatmentp
cell
imbal
persist
case
spontan
inact
treat
dog
respond
poorli
normal
dog
respond
well
treatmentp
human
number
drug
especi
procainamid
hydralazin
isoniazid
penicillamin
sever
anticonvuls
contracept
known
precipit
exacerb
system
lupu
erythematosusv
ib
vaccin
modifi
live
viru
product
contain
distemp
hepat
parainfluenza
parvoviru
antigen
suspect
precipit
system
lupu
erythematosu
dog
tissu
damag
system
lupu
erythematosu
appear
due
type
iii
hypersensit
reaction
new
zealand
black
mous
fl
hybrid
new
zealand
black
mous
new
zealand
white
mous
experi
lupuslik
diseas
mani
similar
system
lupu
erythematosu
humansv
ib
dog
serolog
abnorm
associ
spontan
canin
system
lupu
erythematosu
transmit
normal
dog
mice
mean
cellfre
extract
thu
suggest
infect
agent
yet
howev
none
dog
develop
overt
system
lupu
erythematosu
indic
factor
involv
pathogenesi
clinic
entiti
report
dog
system
lupu
erythematosu
lower
level
circul
thymic
factor
normal
dog
analog
situat
human
coloni
dog
obtain
mate
male
femal
system
lupu
erythematosu
fl
gener
clinic
sign
subsequ
breed
dog
gener
affect
clinic
sign
common
mark
gener
affect
dog
depress
suppressor
cell
activ
decreas
level
serum
thymulin
decreas
percentag
circul
cell
coloni
dog
lyon
franc
greater
dog
ana
carrier
dog
experi
diseasep
coloni
strong
associ
dog
leukocyt
antigen
dla
phenotyp
occurr
system
lupu
erythematosu
posit
associ
dlaal
neg
associatedlp
high
incid
ana
posit
also
found
english
cocker
spaniel
breed
colonyl
clinic
sign
associ
system
lupu
erythematosu
vari
changeabl
phenomen
clinic
variabl
abil
mimic
numer
diseas
system
lupu
erythematosu
call
great
imit
dog
system
lupu
erythematosu
uncommon
diseas
dog
incid
estim
canin
popul
age
predilect
averag
year
least
studi
male
overrepres
ratio
breed
predilect
also
describ
colli
shetland
sheepdog
poodl
german
shepherd
dog
common
manifest
fever
constant
irregularli
cyclic
polyarthr
noneros
nondeform
proteinuria
gil
skin
diseas
present
greater
casesv
consequ
muscl
wast
make
dog
look
much
older
rel
common
manifest
includ
anemia
leukopenia
peripher
lymphadenopathi
splenomegali
oral
ulcersf
syndrom
report
associ
canin
system
lupu
erythematosu
pericard
thrombocytopenia
polymyos
myocard
pneumon
pleuriti
neurolog
disord
seizur
mening
myeliti
psychos
polyneuropathi
lymphedema
cutan
manifest
canin
system
lupu
erythematosu
extrem
divers
includ
seborrh
skin
diseas
alopecia
diffus
region
erythema
cutan
mucocutan
vesiculobul
ulcer
disord
footpad
ulcer
hyperkeratosi
discoid
lupu
erythematosu
refractori
secondari
bacteri
pyoderma
pannicul
lupu
profundu
nasal
dermat
see
fig
f
h
skin
lesion
may
multifoc
gener
commonli
involv
area
skin
poorli
protect
hair
face
especi
nose
lip
pinna
erect
limb
especi
cranial
aspect
thorac
limb
axilla
groin
ventral
abdomen
may
exacerb
induc
exposur
sunlight
pruritu
variabl
scar
common
occasion
dog
experi
acut
facial
hemifaci
edema
castrat
male
bichon
frise
system
lupu
erythematosu
eros
ulcer
lip
extern
auditori
meati
later
thorax
axilla
prepuc
metatarsi
footpadss
histopatholog
find
earli
noninflammatori
subepiderm
blister
late
subepiderm
vesicl
subjac
neutrophil
igg
autoantibodi
noncollagen
aminoterminu
type
vii
collagen
bullou
system
lupu
erythematosu
antigen
detect
suggest
analog
socal
type
bullou
system
lupu
erythematosu
human
cat
system
lupu
erythematosu
rare
report
cat
incid
estim
felin
hospit
visit
appar
sex
predilect
affect
cat
rang
year
old
siames
persian
himalayan
cat
may
predispos
syndrom
report
includ
hematolog
abnorm
neurolog
behavior
abnorm
fever
lymphadenopathi
polyarthr
myopathi
oral
ulcer
conjunct
renal
failur
subclin
pulmonari
diseas
affect
cat
cutan
dermatolog
abnorm
includ
seborrh
skin
diseas
exfoli
erythroderma
erythemat
scale
crust
alopec
scar
dermat
commonli
involv
face
see
fig
pinna
paw
see
fig
differenti
diagnosi
cutan
system
lupu
erythematosu
lengthi
owe
vari
changeabl
cutan
manifest
disord
typic
altern
diagnos
seborrh
skin
diseas
dermatophytosi
bacteri
follicul
demodicosi
food
hypersensit
scabi
pemphigu
vulgari
bullou
pemphigoid
epidermolysi
bullosa
acquisita
discoid
lupu
erythematosu
erythema
multiform
necrolyt
migratori
erythema
leishmaniasi
toxic
epiderm
necrolysi
candidiasi
epitheliotrop
lymphoma
definit
diagnosi
system
lupu
erythematosu
often
one
challeng
task
medicin
diseas
variabl
clinicopatholog
present
dogmat
diagnost
categor
imposs
clinicopatholog
abnorm
demonstr
depend
organ
system
involv
may
includ
anemia
nonregen
hemolyt
without
posit
direct
coomb
test
result
thrombocytopenia
without
posit
platelet
test
result
antiplatelet
antibodi
leukopenia
leukocytosi
proteinuria
hypergammaglobulinemia
polyclon
steril
synovi
exud
obtain
arthrocentesisf
posit
lupustyp
anticoagul
test
result
report
dog
hemolysi
pulmonari
thromboembol
nephrot
syndrom
polyarthropathi
thrombocytopeniap
lupu
erythematosu
le
cell
test
may
yield
posit
result
patient
variabl
day
day
steroidlabil
lack
sensit
specif
assay
discontinu
mani
lead
laboratori
human
medicinef
ana
test
current
consid
sensit
serolog
test
system
lupu
erythematosusfv
yield
posit
result
case
activ
system
lupu
erythematosu
specif
testsf
yield
posit
result
dog
infecti
diseas
particularli
leishmaniasi
control
dog
gener
result
differ
laboratori
compar
import
record
titer
compar
normal
laboratori
normal
dog
may
high
titer
pattern
nuclear
fluoresc
homogen
reticulonodular
pattern
common
canin
system
lupu
erythematosu
titer
pattern
appear
littl
specif
dog
catsf
author
indic
speckl
homogen
ana
pattern
common
dog
autoimmun
connect
tissu
diseasesp
clear
constant
correl
clinic
diseas
activ
posit
ana
titer
though
usual
progress
decreas
titer
success
therapi
decreas
ana
titer
alway
occur
clinic
remiss
must
rememb
ana
detect
time
time
probabl
diseas
well
healthi
animalsf
thu
posit
ana
titer
must
alway
interpret
light
critic
histor
physic
laboratori
data
prepar
protozoan
crithidia
lucilia
becom
commerci
avail
assay
patient
sera
antibodi
nativ
dna
larg
survey
employ
substrat
dog
cat
report
although
preliminari
report
indic
assay
rare
posit
dog
system
lupu
erythematosu
posit
ana
titersf
suggest
dog
rare
form
antibodi
nativ
dna
posit
result
test
occur
femal
beauceron
system
lupu
erythematosu
well
two
femal
puppi
standard
farr
test
radioimmunoassay
measur
antin
dna
antibodi
human
unsatisfactori
dog
result
numer
falseposit
result
newer
techniqu
employ
specif
reagent
elisa
format
reveal
antidoublestrand
dna
antibodi
detect
igg
antibodi
individu
histon
hi
h
h
h
human
patient
system
lupu
erythematosu
ananegativel
patient
uniqu
anticytoplasm
antibodi
antiro
detect
tradit
ana
test
substrat
mous
rat
liver
employ
result
special
substrat
calf
thymu
normal
human
lymphocyt
human
epitheli
tissu
cultur
line
need
patient
import
autoantibodi
system
dog
cat
unknown
could
howev
explain
neg
ana
result
occasion
obtain
dog
system
lupu
erythematosusvv
one
studi
sera
dog
evalu
ana
extract
nuclear
antigen
ena
includ
ro
ribonuclear
protein
antigen
ena
posit
dog
system
lupu
erythematosu
none
roposit
ena
specif
system
lupu
erythematosu
howev
result
posit
healthi
dog
dog
diseas
howev
newer
techniqu
shown
dog
antihiston
antibodi
posit
antiena
antibodi
detect
greater
case
human
antihiston
autoantibodi
associ
druginduc
system
lupu
erythematcsusf
two
antiena
antibodi
highli
specif
canin
system
lupu
erythematosu
antism
antibodi
found
case
antihnrnp
g
found
case
autoantibodi
usual
test
commerci
avail
antiena
test
human
medicin
anoth
novel
canin
autoantibodi
antihnrnp
found
schnauzer
polyarthritisf
studi
demonstr
dog
may
manifest
differ
autoantibodi
human
test
techniqu
may
adapt
canin
presum
cat
investig
attempt
better
understand
lupu
erythematosu
human
studi
subset
patient
basi
one
clinic
characterist
set
histopatholog
immunopatholog
find
serolog
studiess
use
subset
approach
may
allow
clinician
gain
insight
prognosi
improv
therapi
presum
pathogenesi
current
three
subset
cutan
lupu
erythematosu
recogn
human
chronic
cutan
discoid
lupu
erythematosu
subacut
cutan
lupu
erythematosu
acut
cutan
lupu
erythematosu
recognit
import
differ
probabl
system
diseas
correl
autoantibodi
detectedv
suggest
diseas
previous
describ
idiopath
ulcer
dermato
subset
canin
felin
diseas
await
studi
dermatohistopatholog
chang
system
lupu
erythematosu
vari
type
gross
morpholog
lesion
may
nondiagnosttcl
characterist
find
interfac
dermat
hydrop
lichenoid
may
involv
hair
follicl
outer
root
sheath
fig
apoptosi
basal
suprabas
cell
may
occur
occasion
apoptot
cell
associ
lymphocyt
satellitosi
common
find
subepiderm
vacuolar
alter
subepiderm
bubbl
focal
thicken
basement
membran
zone
fig
dermal
mucinosi
uncommon
find
intrabas
subepiderm
vesicl
leukocytoclast
vascul
lupu
erythematosu
pannicul
see
chap
human
chang
often
present
skin
lesion
least
week
old
direct
immunofluoresc
immunohistochem
test
reveal
deposit
immunoglobulin
complement
basement
membran
zone
often
known
posit
lupu
band
variabl
posit
result
reflect
differ
laboratori
techniqu
lesion
select
age
activ
lesion
previou
current
glucocorticoid
therapi
possibl
factor
addit
immunoreact
may
found
basement
membran
zone
skin
mani
condit
includ
sundamag
skin
saw
case
canin
solar
dermat
posit
basement
membran
fluoresc
though
controversi
posit
lupu
band
test
lesion
skin
consid
diagnost
howev
human
posit
result
nonlesion
sunprotect
site
correl
well
diagnosi
system
lupu
erythematosu
dog
commonli
detect
immunoreact
iga
igm
commonli
detect
human
often
possibl
distinguish
system
lupu
erythematosu
discoid
lupu
erythematosu
basi
direct
immunofluoresc
test
lesion
sunexpos
normal
skin
human
patient
system
lupu
erythematosu
sunexpos
normal
skin
may
posit
lupu
band
case
wherea
rare
occur
discoid
lupu
erythematosusf
criterion
valu
hairi
dog
cat
wherein
normal
skin
usual
neg
human
recommend
biopsi
taken
edemat
lesion
lesion
posit
biopsi
taken
lesion
month
old
posit
less
month
old
skin
telangiectas
sampl
lesion
posit
regardless
etiolog
glucocorticoid
immunomodul
therapi
termin
possibl
week
prior
biopsyf
singl
laboratori
test
diagnost
system
lupu
erythematosu
number
group
produc
set
classif
criteria
make
diagnosi
although
criteria
acknowledg
valid
human
valid
criteria
dog
cat
veterinarian
must
reli
recognit
multisystem
diseas
especi
joint
skin
kidney
oral
mucosa
hematopoiet
system
posit
ana
result
confirmatori
histopatholog
immunopatholog
find
involv
skin
oral
mucosa
indirect
immunofluoresc
test
neg
lupu
erythematosu
american
rheumat
associ
develop
criteria
diagnosi
system
lupu
erythematosu
human
modifi
also
appli
dog
minor
modif
primarili
reflect
humor
immunolog
respons
canin
tabl
dog
experi
four
modifi
criteria
given
observ
period
system
lupu
erythematosu
also
suggest
probabl
diagnosi
system
lupu
erythematosu
appropri
three
criteria
present
polyarthr
ana
present
though
criteria
help
guidelin
must
use
cautious
human
numer
situat
may
lead
fals
diagnosi
base
american
rheumat
prognosi
system
lupu
erythematosu
gener
unpredict
depend
organ
involvedf
gener
earlier
diagnosi
made
better
prognosi
dog
appear
patient
joint
skin
muscl
diseas
respond
reliabl
medic
maintain
rel
long
period
clinic
remiss
hand
dog
sever
hemolyt
anemia
thrombocytopenia
often
respond
satisfactorili
system
glucocorticoid
requir
immunomodul
drug
splenectomi
anim
glomerulonephr
regularli
experi
progress
renal
failur
spite
therapi
find
indic
poor
prognosi
therapi
system
lupu
erythematosu
must
individu
initi
agent
choic
probabl
larg
dose
system
glucocorticoid
eg
mgkg
prednison
system
glucocorticoid
unsatisfactori
immunomodul
drug
may
use
azathioprin
imuran
given
oral
mgkg
dog
chlorambucil
leukeran
given
oral
mgkg
splenectomi
may
need
patient
sever
hemolyt
anemia
thrombocytopenia
cyclophosphamid
mgkg
oral
day
week
may
given
acut
episod
hemolyt
anemiap
vincristin
mgkg
intraven
weekli
may
use
thrombocytopenia
sever
levamisol
levasol
given
oral
mglkg
occasion
benefici
dog
human
system
lupu
erythematosusf
combin
levamisol
mgkg
maximum
dose
mg
prednison
report
give
good
result
canin
case
remiss
last
month
year
prednison
initi
dose
mglkg
twice
daili
taper
month
longterm
therapi
consist
levamisol
dog
treat
experienc
unaccept
side
effect
neutropenia
excit
behavior
aggress
levamisolep
chrysotherapi
inject
aurothioglucos
oral
auranofin
occasion
use
reduc
glucocorticoid
requir
dog
would
contraind
patient
renal
diseas
aspirin
occasion
effect
manag
case
dog
human
drug
use
human
patientsdapson
antiandrogen
antimalari
colchicin
fatti
acidsar
undetermin
benefit
dog
cat
plasmapheresi
use
enhanc
initi
respons
chemotherapi
dog
human
sever
system
lupu
erythematosu
techniqu
current
use
research
tool
hazard
expens
murin
lupu
erythematosu
function
elimin
helper
cell
subset
suppress
autoantibodi
format
prevent
retard
diseasef
human
treatment
antibodi
induc
longlast
decreas
diseas
activ
patient
sever
cutan
lupu
erythematosusv
patient
system
lupu
erythematosu
prone
infectionsp
thu
infect
must
identifi
quickli
treat
aggress
follow
statement
made
prognosi
dog
system
lupu
erythematosu
dead
within
year
diagnosi
made
either
result
natur
renal
diseas
septicemia
druginduc
caus
owe
euthanasia
dog
respond
well
therapi
often
glucocorticoid
alon
often
experi
longterm
remiss
alternateday
therapyf
dog
diseas
control
well
therapi
sever
month
remain
prolong
drugfre
rernissionf
sever
report
indic
peopl
close
contact
dog
system
lupu
erythematosu
hightit
ana
greater
clinic
serolog
evid
system
lupu
erythematosu
compar
nonexpos
human
be
discoid
lupu
erythematosu
cutan
lupu
erythematosu
second
common
immunemedi
dermat
dog
although
remain
uncommon
describ
cat
appear
rare
canin
discoid
lupu
erythematosu
rel
benign
cutan
diseas
system
lnvolvementp
relationship
progress
canin
system
lupu
erythematosu
report
diseas
shown
good
model
human
disord
sun
exposur
aggrav
diseas
case
suggest
photosensit
play
role
pathogenesi
human
demonstr
lymphocyt
infiltr
skin
lesion
discoid
system
lupu
erythematosu
predominantli
cell
helper
cell
predomin
discoid
lupu
wherea
suppressor
cell
predomin
system
varieti
dog
plasma
cell
promin
featur
share
human
suggest
b
lymphocyt
may
import
differ
pathogenesi
may
occur
shetland
sheepdog
discoid
lupu
erythematosu
indirect
immunofluoresc
test
antibodi
deposit
basement
membran
zone
western
immunoblot
reveal
protein
target
autoantibodi
correspond
known
basement
membran
zone
componentsf
current
hypothesi
concern
pathogenesi
lesion
format
present
discuss
system
lupu
erythematosu
dog
probabl
strong
sex
predilect
femal
male
report
predispos
age
predilect
report
colli
german
shepherd
shetland
sheepdog
siberian
huski
brittani
spaniel
german
shorthair
pointer
demonstr
discoid
lupu
erythematosu
report
account
canin
dermatos
examin
one
univers
small
anim
practicep
clinic
sign
canin
discoid
lupu
erythematosu
initi
includ
depigment
erythema
scale
nose
fig
earli
depigment
manifest
slate
blue
gray
color
chang
see
fig
help
earli
chang
convers
normal
rough
cobblestonelik
architectur
nasal
planum
smooth
surfac
see
fig
later
lesion
commonli
includ
eros
ulcer
crust
initi
lesion
tend
occur
dorsal
junction
nasal
planum
hair
skin
along
ventral
medial
aspect
alar
fold
typic
time
nasal
involv
becom
extens
lesion
may
spread
bridg
nose
less
commonli
lesion
may
visibl
periocularli
pinna
see
fig
distal
limb
genit
lip
may
also
involv
see
fig
small
punctat
ulcer
may
detect
oral
caviti
see
fig
commonli
involv
tongu
palat
see
fig
occasion
dog
present
lesion
pinna
nasodigit
hyperkeratosisp
pruritu
pain
variabl
scar
variabl
degre
perman
leukoderma
common
rare
deepli
ulcer
nasal
lesion
damag
arteriol
result
episod
pulsatil
hemorrhag
affect
dog
otherwis
healthi
discoid
lupu
erythematosu
dog
commonli
exacerb
precipit
exposur
ultraviolet
light
thu
diseas
often
sever
summer
part
world
sunni
climat
like
mani
dog
previous
refer
nasal
solar
dermat
colli
nose
actual
discoid
lupu
erythematosu
pemphigu
foliaceu
pemphigu
erythematosu
squamou
cell
carcinoma
report
rare
develop
chronic
discoid
lupu
erythematosu
skin
lesion
see
fig
caus
rare
develop
squamou
cell
carcinoma
like
multifactorialf
report
case
discoid
lupu
activ
year
photoprotect
use
chronic
inflam
depig
skin
also
seen
squamou
cell
carcinoma
occur
nasal
lesion
chronic
dermatomyos
thu
depigment
ultraviolet
light
exposur
chronic
irrit
may
import
diseas
affect
nasal
region
cat
discoid
lupu
erythematosu
appear
rare
cat
age
breed
sex
predilect
report
lesion
common
pinna
face
erythema
scale
crust
alopecia
pruritu
variabl
nasal
dermat
depigment
less
common
fig
lesion
may
sever
exposur
sunlight
increas
affect
cat
otherwis
healthi
common
differenti
diagnosi
includ
nasal
solar
dermat
nasal
depigment
vitiligolik
diseas
pemphigu
erythematosu
pemphigu
foliaceu
trauma
dermatomyos
epitheliotrop
lymphoma
drug
reaction
uveodermatolog
syndrom
contact
dermat
system
lupu
erythematosu
definit
diagnosi
discoid
lupu
erythematosu
base
histori
physic
examin
skin
biopsi
immunopatholog
may
aid
diagnosi
dog
thought
requir
definit
diagnosi
falseposit
falseneg
result
result
routin
laboratori
determin
hemogram
serum
chemistri
urinalysi
serum
protein
electrophoresi
usual
unremark
ana
le
cell
test
almost
alway
yield
neg
result
posit
ana
titer
low
one
report
indic
dog
discoid
lupu
erythematosu
posit
antiena
antiro
respectivelyp
histopatholog
skin
biopsi
reveal
interfac
dermat
hydrop
lichenoid
fig
focal
hydrop
degener
basal
epiderm
cell
pigmentari
incontin
focal
thicken
basement
membran
zone
apoptot
keratinocyt
mark
accumul
mononuclear
cell
plasma
cell
around
dermal
vessel
appendag
import
histopatholog
featur
discoid
lupu
erythematosu
dermal
mucinosi
variabl
degre
also
common
featur
discoid
lupu
erythematosu
immunopatholog
test
reveal
deposit
immunoglobulin
complement
basement
membran
zone
would
appear
import
test
individu
immunoglobulin
class
igg
igm
iga
may
demonstr
immunoglobulin
human
recommend
edemat
lesion
biopsi
lesion
posit
telangiectat
area
biopsi
telangiectat
skin
lesion
dermatosi
posit
lesion
less
month
old
biopsi
lesion
posit
addit
topic
system
glucocorticoid
therapi
may
lead
falseneg
immunopatholog
find
think
immunopatholog
test
requir
diagnosi
discoid
lupu
erythematosu
instanc
immunopatholog
test
also
consid
inferior
support
diagnosi
base
histopatholog
criteria
indirect
immunofluoresc
test
gener
neg
discoid
lupu
erythematosu
though
one
dog
autoantibodi
basement
membran
zone
reportedf
prognosi
discoid
lupu
erythematosu
usual
therapi
probabl
need
continu
life
mark
depigment
predispos
sunburn
therapi
discoid
lupu
erythematosu
must
appropri
individualf
mild
case
may
control
case
benefit
avoid
exposur
intens
sunlight
pm
use
topic
sunscreen
use
topic
glucocorticoid
see
chap
initi
topic
glucocorticoid
therapi
success
potent
agent
betamethason
fluocinolon
dmso
synot
appli
everi
hour
dermatosi
remiss
topic
glucocorticoid
appli
need
daili
forth
less
potent
agent
eg
hydrocortison
may
suffici
mainten
anecdot
report
indic
topic
applic
cyclosporin
effect
case
imonth
cours
system
prednison
mglkg
oral
remiss
achiev
help
topic
agent
may
suffici
maintain
remiss
though
frequent
effect
sole
therapi
system
vitamin
e
iv
daili
recommend
may
benefici
effect
vitamin
e
appear
lag
phase
benefit
recogn
clinic
system
glucocorticoid
may
use
concurr
period
vitamin
e
administ
hour
feed
two
us
dw
whm
good
success
case
oral
administr
product
contain
omegaszomegaf
fatti
acid
dvm
derm
cap
use
product
instead
vitamin
e
variou
combin
fatti
acid
vitamin
e
treatment
use
success
case
potent
drug
may
given
initi
remiss
maintain
fatti
acid
vitamin
e
benign
treatment
effect
dog
tetracyclin
niacinamid
combin
may
effect
case
see
chap
dog
kg
dosag
mg
drug
dog
kg
dosag
mg
tetracyclineniacinamid
combin
produc
effect
within
week
refractori
case
dog
cat
owner
think
better
control
absolut
requir
system
glucocorticoid
mglkg
prednisolon
prednison
given
oral
often
effect
sever
refractori
case
system
drug
may
ad
treatment
regimen
azathioprin
mglkg
oral
dog
chlorambucil
mglkg
oral
owner
understand
discoid
lupu
erythematosu
rare
lifethreaten
diseas
potent
immunomodul
drug
could
caus
sever
side
effect
human
discoid
lupu
erythematosu
often
respons
antimalari
drugschloroquin
aralen
hydroxychloroquin
plaquenil
quinacrin
atabrm
drug
may
use
dog
well
dosag
efficaci
toxic
need
care
evalu
drug
occasion
found
benefici
human
retinoid
dapson
gold
oral
inject
use
latter
compound
dog
current
unknown
bilater
rotat
flap
success
use
treatment
chronic
medic
refractori
case
canin
nasal
result
clinicopatholog
studi
five
shetland
sheepdog
two
colli
socal
idiopath
ulcer
dermatosi
led
investig
conclud
syndrom
renam
vesicular
cutan
lupu
erythematosu
see
chap
result
recent
patholog
immunopatholog
studi
german
shorthair
pointer
socal
hereditari
lupoid
dermatosi
led
investig
conclud
syndrom
renam
exfoli
cutan
lupu
erythematosu
see
chap
cryoglobulin
cryofibrinogen
protein
precipit
serum
plasma
respect
cool
redissolv
rewarmingi
cryoglobulin
classifi
three
type
accord
characterist
type
cryoglobulin
compos
sole
monoclon
immunoglobulin
free
light
chain
benc
jone
protein
commonli
associ
lymphoprolif
disord
type
ii
cryoglobulin
compos
monoclon
polyclon
immunoglobulin
commonli
associ
autoimmun
connect
tissu
diseas
type
iii
cryoglobulin
compos
polyclon
immunoglobulin
occur
infect
autoimmun
disord
connect
tissu
diseas
essenti
form
also
may
occur
underli
caus
identifi
cutan
sign
associ
cryoglobulin
cryofibrinogen
due
vascular
insuffici
obstruct
stasi
spasm
thrombosi
occur
microthrombi
vascul
cryoglobulinemia
cryofibrinogenemia
rare
report
caus
skin
diseas
dog
catsf
associ
autoantibodi
direct
erythrocyt
cold
agglutinin
diseas
cold
hemagglutinin
diseas
cryopath
hemolyt
anemia
autoimmun
disord
associ
coldreact
usual
igm
erythrocyt
autoantibodi
cryopath
autoantibodi
activ
colder
temperatur
wide
rang
thermal
activ
two
form
recogn
dog
first
associ
cold
agglutinin
igm
antibodi
second
form
non
agglutin
type
usual
associ
igg
latter
form
rarer
known
caus
skin
diseas
dog
combin
cryoglobulinemia
lgg
igm
cryofibrinogenemia
reportedr
cold
agglutinin
diseas
repres
type
ii
hypersensit
reaction
associ
idiopathi
lead
poison
dog
upper
respiratori
infect
lead
poison
idiopathi
cat
clinic
sign
cryoglobulinemia
cryofibrinogenemia
variabl
relat
anemia
intracapillari
cold
hemagglutin
skin
lesion
includ
pain
erythema
purpura
acrocyanosi
necrosi
ulcer
skin
lesion
gener
involv
extrem
paw
pinna
nose
tip
tail
see
fig
precipit
exacerb
exposur
cold
hemoglobinemia
may
also
present
tailtip
necrosi
report
two
litter
birman
kitten
queen
base
blood
group
test
queen
one
tom
presumpt
diagnosi
neonat
isoerythrolysi
involv
cold
agglutinin
made
tip
tail
becam
necrot
within
first
week
life
thought
pinna
paw
nose
neonat
protect
cold
close
contact
queen
kitten
surviv
pend
sever
intravascular
hemolysi
differenti
diagnosi
includ
vascul
system
lupu
erythematosu
dermatomyos
dissemin
intravascular
coagul
frostbit
definit
diagnosi
cold
agglutinin
diseas
made
histori
physic
examin
demonstr
signific
titer
cold
agglutinin
vitro
autohemagglutin
blood
room
temperatur
diagnost
coldreact
autoantibodi
blood
heparin
ethylenediaminetetraacet
acid
edta
allow
coolon
slide
thu
permit
autoagglutin
readili
visibl
macroscop
reaction
accentu
cool
blood
revers
warm
blood
doubt
case
confirm
via
coomb
test
complet
test
perform
coomb
reagent
activ
igm
caution
interpret
cold
coomb
test
warrant
normal
dog
cat
may
titer
cryoprecipit
level
may
crude
determin
allow
venou
blood
collect
warm
syring
clot
minut
serum
citrat
plasma
cool
gellik
precipit
form
redissolv
upon
rewarm
precipit
remov
serum
plasma
globulin
fibrinogen
level
without
precipit
may
compar
give
level
cryoglobulin
cryofibrinogen
normal
dog
mean
level
gli
cryoglobulin
gl
cryofibrinogen
wherea
affect
dog
level
respectivelyp
skin
biopsi
usual
reveal
necrosi
ulcer
often
secondari
suppur
chang
fortuit
sampl
section
may
show
vascul
thrombot
necrot
blood
vessel
blood
vessel
contain
amorph
eosinophil
substanc
consist
larg
precipit
cryoglobulin
diffus
edema
extravas
erythrocyt
homogen
dermal
collagen
also
occur
see
fig
prognosi
cryoglobulinemia
cryofibrinogenemia
vari
underli
caus
therapi
includ
correct
underli
caus
possibl
avoid
cold
immunosuppress
drug
regimen
eg
glucocorticoid
azathioprin
see
chap
graftversushost
diseas
wellrecogn
result
bone
marrow
transplant
dog
humansv
lb
diseas
occur
whenev
lymphoid
cell
immunocompet
donor
introduc
histoincompat
recipi
incap
reject
diseas
result
donor
cell
respons
recipi
transplant
antigen
dog
human
bone
marrow
graft
donor
genet
ident
major
histocompat
mhc
antigen
follow
signific
graftversushost
diseas
recipi
despit
postgraft
immunosuppress
therapi
henc
minor
histocompat
antigen
import
develop
diseas
princip
target
organ
skin
liver
intestin
tract
dog
acut
graftversushost
diseas
develop
week
graft
character
erythroderma
jaundic
diarrhea
gramneg
infect
chronic
graftversushost
diseas
develop
month
graft
character
exfoli
erythroderma
ulcer
dermat
ascit
gramposit
infect
diagnosi
base
histori
physic
examin
skin
biopsi
histopatholog
find
acut
graftversushost
diseas
includ
vari
degre
dermal
lymphoid
infiltr
interfac
dermat
hydrop
lichenoid
apoptosi
satellitosi
lymphocyt
exocytosi
apoptosi
also
target
follicular
epitheliumi
chang
compar
similar
occur
erythema
multiform
chronic
graftversushost
diseas
one
find
variabl
sclerodermoid
poikilodermat
chang
immunohistochemistri
acut
canin
graftversushost
diseas
studi
six
dog
similar
describ
humansv
epiderm
follicular
keratinocyt
affect
skin
upregul
icaml
mhc
ii
similar
found
erythema
multiformef
howev
overal
lymphocyt
infiltr
two
diseas
differ
although
diseas
cell
graftversushost
diseas
fewer
dermal
cell
cdi
cdn
dendrit
cell
b
cell
occur
erythema
multiform
find
suggest
mechan
diseas
similar
two
diseas
though
erythema
multiform
addit
patholog
pathway
whether
relat
stage
diseas
unknown
dog
erythema
multiform
may
chronic
diseas
dog
experiment
induc
graftversushost
diseas
epiderm
follicular
icaml
express
may
playa
key
role
tether
cell
enabl
subsequ
interact
cell
keratinocytesv
activ
cell
produc
storm
cytokin
includ
interferon
ifn
tnfa
mediat
recruit
activ
effector
cell
includ
addit
lymphocyt
macrophag
natur
killer
cell
attack
host
donor
tissu
contactdepend
mechan
perform
solubl
mediat
tnfa
therapi
graftversushost
diseas
variou
combin
system
glucocorticoid
azathioprin
cyclosporin
methotrex
antithymocyt
serum
partial
unpredict
effect
combin
mycophenol
mofetil
cyclosporin
demonstr
synerg
benefici
effect
still
iimitedp
leflunomid
combin
prednison
cyclosporin
report
virtual
elimin
allograft
reject
respons
cutan
advers
drug
reaction
drug
erupt
drug
allergi
dermat
medicamentosa
dog
cat
uncommon
variabl
prurit
pleomorph
cutan
mucocutan
reaction
drug
advers
reaction
drug
common
human
cutan
reaction
one
common
drug
respons
skin
erupt
may
administ
oral
topic
inject
inhal
incid
cutan
advers
drug
reaction
dog
cat
report
respect
canin
felin
dermatolog
case
examin
one
univers
practic
human
incid
report
hospit
patient
per
cours
drug
therapi
even
number
suspect
mechan
accur
record
incid
drug
reactionsp
advers
drug
reaction
may
divid
two
major
group
predict
usual
dosedepend
relat
pharmacolog
action
drug
unpredict
idiosyncrat
often
doseindepend
relat
individu
immunolog
respons
genet
differ
suscept
patient
idiosyncraci
intoler
often
relat
metabol
enzymat
defici
drug
metabolit
gener
cytochrom
function
oxidas
phase
enzym
also
oxid
metabol
enzym
present
reactiv
drug
metabolit
need
detoxifi
phase
ii
enzym
epoxid
hydrolas
glutathionestransferas
prevent
toxic
thu
two
place
allow
inappropri
gener
andor
accumul
toxic
reactant
toxic
parent
compound
human
slow
acetyl
contribut
sulfonamid
drug
reaction
famili
anticonvuls
drug
reaction
link
inherit
detoxif
hypothesi
drug
reaction
associ
sulfonamid
anticonvuls
includ
oxid
cytochrom
chemic
reactiv
metabolit
either
liver
hepat
cytochrom
secondari
transfer
skin
keratinocyt
epiderm
cytochrom
decreas
detoxif
reactiv
metabolit
bind
protein
induc
immunolog
respons
mani
cutan
effect
certain
drug
predict
instanc
mani
anticanc
immunosuppress
drug
caus
alopecia
purpura
poor
wound
heal
increas
suscept
infect
effect
cellular
biolog
doxorubicin
typic
caus
alopecia
begin
head
extend
ventral
neck
thorax
abdomenp
hyperpigment
pruritu
may
also
occur
immunolog
reaction
involv
cutan
drug
reaction
includ
type
ii
iii
iv
hypersensit
reaction
newer
techniqu
may
help
determin
underli
immun
respons
type
drug
reactionsf
addit
immunolog
reaction
may
occur
evidenc
druginduc
develop
erythema
multiform
toxic
epiderm
necrolysi
superfici
suppur
necrolyt
dermat
miniatur
schnauzer
though
mechan
reaction
unknown
thought
immunolog
mechan
may
play
role
human
patient
system
lupu
erythematosu
atopi
thought
predispos
cutan
drug
reaction
observ
made
dog
cat
drug
may
caus
erupt
tabl
though
certain
drug
frequent
associ
cutan
advers
drug
reaction
common
drug
recogn
produc
idiosyncrat
cutan
advers
drug
reaction
dog
topic
agent
sulfonamid
especi
trimethoprimpotenti
tribrissen
penicillin
cephalosporin
levamisol
diethylcarbamazinef
cat
common
caus
topic
agent
penicillin
cephalosporin
sulfonamidesp
cutan
advers
drug
reaction
mimic
virtual
dermatosi
see
tabl
fig
h
human
common
morpholog
pattern
exanthemat
urticaria
angioedema
fix
drug
eruptionp
dog
common
reaction
contact
dermat
exfoli
dermat
pruritu
selfinduc
lesion
maculopapular
erupt
erythema
multiformef
cat
common
reaction
contact
dermat
pruritu
selfinduc
lesionsf
age
sex
predilect
report
canin
felin
cutan
drug
reactionsp
gener
breed
predilect
evid
though
poodl
bichon
frise
yorkshir
terrier
silki
terrier
pekinges
maltes
terrier
fuzzi
hair
coat
predispos
local
inject
reaction
especi
rabi
vaccinerf
doberman
pinscher
sulfonamid
miniatur
schnauzer
sulfonamid
gold
shampoo
superfici
suppur
necrolyt
dermat
reactionsf
one
studi
cutan
advers
drug
reaction
follow
breed
found
increas
risk
shetland
sheepdog
dalmatian
yorkshir
terrier
miniatur
poodl
miniatur
schnauzer
australian
shepherd
old
english
sheepdog
scottish
terrier
wirehair
fox
terrier
greyhound
although
human
hiv
infect
increas
risk
drug
reaction
cat
cutan
advers
drug
reaction
flyposit
felvposit
although
specif
type
reaction
relat
one
drug
certain
reaction
common
certain
drug
syndrom
superfici
suppur
necrolyt
dermat
miniatur
schnauzer
associ
shampoo
see
fig
adult
miniatur
schnauzer
either
sex
show
cutan
system
sign
within
hour
shampoo
usual
insecticid
lesion
may
widespread
primarili
ventral
includ
erythemat
papul
plaqu
develop
pustulosi
becom
pain
necrot
ulcer
lesion
regress
spontan
within
week
symptomat
therapi
system
sign
includ
pyrexia
depress
neutrophilia
drug
erupt
associ
system
sign
fatal
outcom
report
two
dog
carprofen
rimadyl
therapyp
skin
lesion
includ
small
pustul
erythemat
macul
crust
eros
histolog
dermal
neutrophil
infiltr
dog
die
spite
immunosuppress
therapi
neutrophil
infiltr
respiratori
tract
propos
two
case
carprofeninduc
condit
similar
sweet
syndrom
human
erythema
multiform
toxic
epiderm
necrolysi
common
administr
sulfonamid
cephalosporin
levamisol
see
fig
c
three
dog
two
treat
trimethoprimsulfonamid
experienc
superfici
pemphigu
featur
erythema
multiform
includ
keratinocyt
apoptosi
neutrophil
satellitosi
drug
erupt
dog
coccidioidomycosi
treat
itraconazol
clinic
histolog
chang
compat
erythema
multiformef
diethylcarbamazin
associ
fix
drug
erupt
especi
scrotum
male
dog
fig
partial
respons
glucocorticoid
treatment
mimic
food
hypersensitivityp
drug
also
report
produc
reaction
clinic
patholog
immunolog
resembl
pemphigu
see
fig
pemphigoid
drug
reaction
associ
ketoconazol
one
case
multipl
drug
other
occur
dog
clinic
histolog
indistinguish
epitheliotrop
lymphoma
report
variou
drug
human
lesion
resolv
spontan
drug
stop
chronic
eosinophil
urticaria
associ
diethylcarbamazinep
unusu
reaction
local
inject
also
well
recogn
fig
one
reaction
focal
vascul
alopecia
follow
subcutan
administr
rabi
vaccin
especi
poodl
yorkshir
silki
terrier
see
discuss
vasculitislt
anoth
local
reaction
pannicul
associ
subcutan
administr
rabi
vaccin
cat
combin
rhinotracheitiscaliciviru
vaccin
product
see
discuss
pannicul
chap
plaquelik
lesion
distinct
interstiti
granulomat
dermat
histopatholog
appear
associ
drug
therapi
humansp
one
us
dw
seen
one
reaction
dog
treat
amoxicillin
clavulan
fig
granulomat
mural
follicul
rare
cutan
reaction
pattern
appar
associ
drug
administr
amitraz
cefadroxyl
topic
lthyroxin
lesion
consist
larg
area
wellcircumscrib
coalesc
alopecia
scale
hyperkeratosi
fig
b
foci
papul
plaqu
eros
crust
may
occur
chronic
lesion
often
smooth
shini
cicatrici
appear
drug
reaction
mimic
mani
differ
dermatos
accur
knowledg
medic
given
patient
obscur
form
dermatosi
imper
drug
erupt
may
occur
drug
given
day
year
day
drug
therapi
stop
erupt
commonli
occur
within
week
initi
therapi
reaction
vascul
atroph
dermatosi
nodul
rabi
vaccin
reaction
may
occur
week
month
drug
administ
present
reliabl
test
diagnosi
drug
erupt
withdraw
drug
watch
disappear
erupt
usual
week
occasion
howev
drug
erupt
persist
week
month
offend
drug
stop
eg
reaction
vaccin
inject
lichenoid
reactionslp
purpos
readministr
offend
drug
determin
whether
erupt
reproduc
undesir
may
danger
differenti
diagnosi
complex
cutan
advers
drug
reaction
may
mimic
virtual
dermatosi
gener
specif
characterist
laboratori
find
indic
drug
erupt
result
vivo
vitro
immunolog
test
usual
disappoint
basophil
degranul
test
report
valuabl
test
detect
hypersensitivityinduc
cutan
advers
drug
reaction
technic
demand
gener
unavail
help
criteria
determin
whether
drug
erupt
like
hypersensit
reaction
occur
minor
patient
receiv
drug
observ
manifest
resembl
known
pharmacolog
action
drug
previou
experi
suspect
drug
known
caus
type
cutan
reaction
lack
altern
caus
could
explain
cutan
reaction
occur
suspect
drug
appropri
timinggener
cutan
advers
drug
reaction
occur
within
first
week
initi
therapi
offend
drug
drug
still
taken
still
present
bodi
prior
exposur
drug
may
toler
without
advers
effect
reaction
hypersensit
reaction
prior
exposur
occur
sensit
could
occur
anim
previous
sensit
cutan
reaction
may
seen
within
hour
day
drug
readministr
dechalleng
resolut
begin
occur
within
week
drug
discontinu
reactionssuch
fix
drug
lichenoid
local
inject
reaction
resolut
may
requir
sever
week
rechalleng
reaction
reproduc
administr
small
dose
drug
crossreact
drug
though
definit
way
document
drug
reaction
gener
recommend
seriou
reaction
may
occur
one
studi
case
cutan
advers
drug
reaction
dog
confirm
often
accident
rechalleng
identifi
specif
caus
cutan
drug
erupt
difficult
mani
patient
receiv
sever
drug
timei
case
reaction
occur
drug
combin
one
drug
toler
recent
possibl
causal
drug
exposur
assess
adapt
drug
implic
criteria
adopt
french
committe
pharmacolog
surveil
human
tabl
clinic
morpholog
drug
reaction
vari
greatli
histolog
find
histolog
pattern
recogn
cutan
advers
drug
reaction
includ
tahl
propos
criteria
implic
drug
caus
cutan
drug
attribut
score
suggest
lesion
began
day
first
administr
drug
less
day
reexposur
culprit
medic
b
inconclus
specif
assess
could
made
c
suggest
criteria
suggest
met
dmg
attribut
score
posit
total
drug
score
eg
consid
suggest
drug
causat
zero
score
consid
inconclus
neg
score
eg
consid
doubt
drug
given
numer
score
base
ad
valu
obtain
three
criteria
perivascular
dermat
pure
spongiot
hyperplast
interfac
dermat
hydrop
lichenoid
vasculitisvasculopathi
fig
intraepiderm
vesiculopustular
dermat
fig
subepiderm
vesicular
dermat
interstiti
dermat
pannicul
eosinophil
may
absent
numerousp
human
eosinophil
may
promin
druginduc
nondruginduc
pemphigu
foliaceusp
syndromessuch
erythema
multiform
toxic
epiderm
necrolysi
superfici
suppur
necrolyt
dermatitishav
characterist
histopatholog
superfici
suppur
necrolyt
dermat
miniatur
schnauzer
character
parakeratosi
superfici
epiderm
suppur
necrosi
epiderm
edema
suppur
perivascular
perifollicular
dermat
fig
similar
chang
may
occur
follicular
epithelium
granulomat
mural
follicul
character
infiltr
eventu
replac
follicular
epithelium
occasion
sebac
gland
granulomat
inflamm
fig
direct
immunofluoresc
immunohistochem
test
drug
reaction
may
reveal
immunoreact
deposit
varieti
nondiagnost
pattern
especi
wall
blood
vessel
basement
membran
zone
prognosi
drug
reaction
usual
good
unless
organ
system
involv
extens
epiderm
necrosi
therapi
drug
reaction
consist
discontinu
offend
drug
treat
symptom
topic
system
medic
indic
avoid
chemic
relat
drug
drug
reaction
may
poorli
respons
glucocorticoid
though
immunolog
mediat
reaction
respond
glucocorticoid
pentoxifyllin
immunosuppress
regimen
see
chap
erythema
multiform
uncommon
acut
usual
selflimit
erupt
skin
mucou
membran
character
distinct
gross
lesion
diagnost
sequenc
patholog
chang
despit
recognit
multipl
etiolog
trigger
caus
pathogenesi
erythema
multiform
fulli
understood
current
thought
repres
hostspecif
cellmedi
hypersensit
reaction
direct
toward
variou
antigen
includ
infect
drug
food
neoplasia
connect
tissu
diseas
recent
studi
indic
immunohistochem
find
skin
lesion
dog
erythema
multiform
acut
graftversushost
diseas
similar
epiderm
follicular
keratinocyt
markedli
express
icaml
mhc
ii
lesser
extent
cdla
express
molecul
like
tether
leukocyt
keep
epithelium
simultan
express
mhc
ii
cdla
provid
alter
keratinocyt
capabl
antigen
present
keratinocyt
adjac
noninflam
epidermi
also
express
icaml
mhc
ii
suggest
upregul
adhes
molecul
may
repres
earli
phase
develop
erythema
multiform
markedli
upregul
keratinocyt
infiltr
cell
involv
lymphocyt
activ
sitespecif
extravas
lymphocyt
tissu
intraepitheli
infiltr
cell
mainli
lymphocyt
smaller
number
lymphocyt
cdi
cdllc
langerhan
cell
increas
number
major
dermal
infiltr
cell
also
lymphocyt
cdi
cdllc
dermal
dendrocyt
increas
number
phenotyp
chang
keratinocyt
canin
erythema
multiform
indic
alter
keratinocyt
eg
drug
infecti
agent
might
primari
factor
diseas
pathogenesiss
regul
icaml
mhc
ii
perhap
product
ifna
cytotox
helper
lymphocyt
allow
tether
keep
lymphocyt
epithelium
keratinocyt
apoptosi
probabl
produc
signal
intraepitheli
lymphocyt
studi
human
erythema
multiform
shown
variou
basement
membran
zone
moleculesintegrin
laminin
collagen
iv
viiar
disrupt
fragrnentedp
subset
human
erythema
multiform
autoantibodi
desmoplakin
ii
well
suprabasilar
acantholysi
skin
biopsi
specimenss
confus
pathogenesi
classif
erythema
multiform
frustrat
human
veterinari
medicin
year
human
erythema
multiform
usual
divid
two
subsetsp
import
distinct
human
common
mild
relaps
cutan
diseas
erythema
multiform
erythema
multiform
minor
often
associ
viral
infect
wherea
sever
form
involv
mucosa
widespread
cutan
diseas
erythema
multiform
major
often
associ
drug
eruptionsp
addit
much
confus
exist
relationship
erythema
multiform
stevensjohnson
syndrom
also
call
erythema
multiform
major
author
toxic
epiderm
necrolysi
lyell
syndrom
overlap
latter
two
entiti
reli
etiolog
clinic
histopatholog
similar
suggest
condit
simpli
repres
differ
aspect
singl
spectrum
diseasesp
howev
unitari
concept
disput
clinic
histolog
ground
use
standard
histopatholog
immunohistochem
techniqu
shown
inflammatori
infiltr
skin
human
erythema
multiform
toxic
epiderm
necrolysi
differ
densiti
natur
erythema
multiform
cellular
infiltr
high
densiti
cellrich
rich
lymphocyt
wherea
toxic
epiderm
necrolysi
infiltr
low
densiti
cellpoor
domin
macrophag
dermal
dendrocytesp
support
differ
pathomechan
shown
dog
studi
apoptosi
canin
skin
diseas
investig
found
keratinocyt
apoptosi
featur
erythema
multiform
toxic
epiderm
necrolysi
least
suggest
two
diseas
howev
conclus
reach
case
share
histopatholog
disord
need
studi
much
confus
classif
stem
terminolog
appli
variou
syndrom
human
lack
agreement
clinic
definit
henc
variou
author
consid
stevensjohnson
syndrom
erythema
multiform
major
differ
divid
erythema
multiform
minor
major
variant
reason
author
propos
term
erythema
multiform
use
describ
form
entiti
stevensjohnson
syndrom
toxic
epiderm
necrolysi
call
stevensjohnson
syndrometox
epiderm
necrolysi
elimin
term
major
veterinari
medicin
confus
compound
common
accept
diagnosi
base
primarili
histopatholog
find
clinic
separ
differ
diseas
becom
realist
human
medicin
first
point
separ
present
case
erythema
multiform
rel
mild
acut
onset
lesion
includ
classic
target
lesion
fever
prodrom
symptom
mucos
involv
usual
mild
limit
oral
case
selflimit
lesion
clear
within
week
confus
occur
case
widespread
may
involv
fever
prodrom
symptom
recent
public
studi
human
patient
requir
hospit
sever
diseas
lesion
compat
erythema
multiform
stevensjohnson
syndrometox
epiderm
necrolysi
clinic
classif
propos
review
consensu
clinic
separ
reachedf
howev
author
wrote
classif
valid
unproven
four
type
lesion
found
case
typic
target
lesion
rais
atyp
target
lesion
flat
atyp
target
lesion
macul
without
blister
two
main
featur
use
separ
case
presenc
typic
target
lesion
extent
bodi
surfac
area
epiderm
detach
case
classifi
one
five
categori
salient
differenti
featur
erythema
multiform
rest
stevensjohnson
syndrometox
epiderm
necrolysi
case
presenc
typic
target
lesion
case
erythema
multiform
addit
erythema
multiform
case
involv
less
bodi
surfac
area
epiderm
detach
classif
scheme
use
signific
correl
clinic
find
caus
histolog
found
erythema
multiform
stevensjohnson
syndrometox
epiderm
necrolysi
erythema
multiform
primarili
associ
infect
particularli
herpesviru
stevensjohnson
syndrometox
epiderm
necrolysi
primarili
associ
drug
erythema
multiform
lesion
may
also
occur
lupu
erythematosu
rowel
syndrom
histopatholog
find
erythema
multiform
case
reveal
predominantli
inflammatori
mononuclear
lichenoid
infiltr
stevensjohnson
syndrometox
epiderm
necrolysi
reveal
predominantli
epiderm
necrosi
minim
inflamm
human
intern
consensu
clinic
classif
adapt
use
dog
multicent
group
canada
europ
unit
state
tabl
possibl
causal
drug
exposur
address
adopt
drug
implic
criteria
use
human
see
tabl
scheme
erythema
multiform
case
flat
rais
target
polycycl
lesion
less
bodi
surfac
affect
erythemat
purpur
macular
patchi
erupt
less
bodi
surfac
show
epiderm
detach
erythema
multiform
case
subclassifi
minor
one
mucos
surfac
involv
major
one
mucos
surfac
affect
three
form
stevensjohnson
syndrometox
epiderm
necrolysi
greater
bodi
surfac
affect
macular
purpur
erupt
greater
one
mucos
surfac
involv
target
polycycl
lesion
classif
scheme
shown
erythema
multiform
associ
drug
exposur
wherea
stevensjohnson
syndrometox
epiderm
necrolysi
case
associ
drug
exposur
histopatholog
find
show
overlap
group
suggest
least
canin
classif
system
biopsi
histopatholog
examin
abl
separ
two
entiti
though
erythema
multiform
case
less
epiderm
necrosi
greater
dermal
inflamm
stevensjohnson
syndrometox
epiderm
necrolysi
case
studi
indic
document
valid
use
classif
system
dog
other
think
histopatholog
find
erythema
multiform
toxic
epiderm
necrolysi
dog
human
quit
differ
major
distinct
still
address
typic
target
lesion
appear
major
featur
diagnosi
erythema
multiform
human
address
dog
typic
target
lesion
defin
highli
regular
welldefin
round
wheallik
erythemat
papul
plaqu
less
cm
diamet
least
three
differ
zone
compos
two
concentr
ring
around
central
disk
fig
central
disk
vari
erythemat
violac
duski
purpur
necrot
may
vesicul
inner
ring
edemat
pale
outer
ring
halo
typic
target
lesion
detect
dog
erythema
multiformep
aspect
need
care
reevalu
veterinari
medicin
erythema
multiform
uncommon
dog
cat
account
respect
canin
felin
dermatolog
case
examin
univers
practicep
erythema
multiform
recogn
dog
associ
infect
drug
therapi
especi
trimethoprimpotenti
sulfonamid
penicillin
cephalosporin
idiopathi
tabl
two
case
druginduc
erythema
multiform
associ
dissemin
intravascular
coagul
erythema
multiform
also
report
manifest
advers
reaction
dietari
substancesp
one
studi
case
canin
erythema
multiform
idiopath
subgroup
idiopath
erythema
multiform
describ
old
dog
occasion
associ
underli
diseas
suggest
immun
dysfunctionp
cat
erythema
multiform
report
associ
drug
therapi
cephalexin
penicillin
aurothioglucos
trimethoprimsulfonamid
amoxicillin
griseofulvin
propylthiouracil
herpesviru
infect
wherein
lesion
may
accompani
upper
respiratori
sign
resolv
respiratori
diseas
resolvesv
prodrom
concurr
clinic
sign
may
reflect
underli
caus
term
multiform
impli
skin
lesion
variabl
usual
character
acut
rather
symmetr
onset
erythemat
macul
see
fig
slightli
elev
papul
spread
peripher
clear
central
produc
annular
target
arciform
pattern
see
fig
urticari
plaqu
vesicl
bulla
combin
thereof
classic
target
iri
doughnut
lesion
papular
plaquelik
lesion
wherein
peripheri
remain
indur
center
clear
ancljor
becom
cyanot
purpur
see
fig
lesion
may
becom
central
vesicular
bullou
eventu
epiderm
necrosi
result
slough
ooz
eros
ulcer
mucos
lesion
similar
onset
symmetri
usual
vesicular
bullou
ulcer
oral
ulcer
often
hemorrhag
coat
grayishwhit
pseudomembran
necrot
epithelium
fibrin
maculopapular
form
erythema
multiform
initi
character
lack
surfac
patholog
lack
scale
crust
ooz
hair
loss
urticari
form
erythema
multiform
character
normal
overli
skin
haircoat
persist
urticari
lesion
oppos
evanesc
natur
wheal
true
urticaria
patient
maculopapular
erupt
usual
asymptomat
anim
becom
system
ill
fever
depress
anorexia
rather
extens
vesiculobul
ulcer
lesion
commonli
affect
bodi
site
dog
includ
cat
lesion
predominantli
vesiculobul
andor
ulcer
fig
trunk
mucocutan
junction
commonli
affectedf
differenti
diagnosi
includ
bacteri
follicul
dermatophytosi
demodicosi
urticaria
vesicular
pustular
disord
definit
diagnosi
base
histori
physic
examin
rule
alteru
laboratori
test
skin
biopsi
skin
biopsi
find
vari
gross
morpholog
lesion
reliabl
distinguish
clinic
mild
sever
form
disorderp
neither
appar
histopatholog
differ
case
suspect
trigger
level
epidermi
lymphocyt
exocytosi
also
note
mild
epiderm
hyperplasia
normal
stratum
corneum
without
ie
idiopath
maculopapular
lesion
character
histolog
hydrop
interfac
dermat
promin
singlecel
apoptosi
keratinocyt
level
epidermi
satellitosi
lymphocyt
macrophag
fig
infundibular
region
hair
follicl
outer
root
sheath
epithelium
often
similarli
affect
absenc
necrosi
ulcer
bacteri
infect
stratum
corneum
orthokeratot
normal
epidermi
show
mild
moder
regular
hyperplasia
superfici
interstiti
rare
dens
lichenoid
inflammatori
infiltr
visibl
urticari
lesion
character
hydrop
interfac
dermat
strike
dermal
edema
fig
dermal
collagen
fiber
becom
vertic
orient
attenu
present
weblik
appear
gossam
collagen
vesiculobul
lesion
character
segment
fullthick
coagul
necrosi
epithelium
fig
superfici
perivascular
interstiti
accumul
predominantli
lymphohistiocyt
cell
typic
subepiderm
cleft
vesicl
format
may
occur
owe
separ
necrot
epithelium
underli
connect
tissu
basement
membran
zone
pigmentari
incontin
common
direct
immunofluoresc
test
usual
yield
neg
result
may
demonstr
igg
igm
epiderm
keratinocyt
around
globoid
bodi
superfici
dermi
associ
dermal
blood
vessel
wallsf
erythema
multiform
may
run
mild
cours
spontan
regress
within
week
underli
caus
sought
correct
whenev
possibl
procedur
also
result
spontan
resolut
erythema
figur
canin
erythema
multiform
major
upper
half
epidermi
undergon
coagul
necrosi
separ
viabl
epidermi
sever
vesiculobul
case
erythema
multiform
requir
support
care
exhaust
search
underli
caus
trigger
factor
identifi
elimin
erythema
multiform
usual
resolv
within
week
human
medicin
use
immunosuppress
drug
especi
glucocorticoid
treatment
erythema
multiform
continu
controversi
given
presum
immunemedi
pathogenesi
erythema
multiform
treatment
immunomodul
drug
would
seem
make
sens
case
elimin
potenti
trigger
factor
achiev
yet
diseas
persist
fact
dog
sever
idiopath
erythema
multiform
success
treat
larg
dose
glucocorticoid
andor
azathioprinef
anecdot
report
suggest
cyclosporin
etretin
may
use
idiopath
erythema
multiform
dog
use
pentoxifyllin
success
case
drug
may
warrant
trial
prior
immunosuppress
drug
idiopath
case
receiv
novel
antigen
hypoallergen
diet
rule
dietrel
diseas
even
idiopath
case
known
spontan
resolv
month
suggest
undocu
antigen
trigger
elimin
toxic
epiderm
necrolysi
rare
variabl
pain
extens
vesiculobul
ulcer
disord
skin
oral
mucosa
dog
cat
human
be
less
extens
cutan
mucos
involv
often
call
stevensjohnson
syndrom
though
confus
veterinari
human
literatur
equat
sever
erythema
multiformep
human
toxic
epiderm
necrolysi
tempor
associ
drug
casesp
fifti
percent
case
stevensjohnson
syndrom
also
drugrelatedp
varieti
drug
caus
associ
toxic
epiderm
necrolysi
dog
see
tabl
flea
dip
implic
dog
cat
experienc
toxic
epiderm
necrolysisp
case
idiopath
although
pathomechan
toxic
epiderm
necrolysi
unknown
immunopatholog
mechan
suggest
also
suggest
druginduc
erythema
multiform
major
toxic
epiderm
necrolysi
may
relat
defect
epiderm
detoxif
drug
byproductsp
fadok
propos
apoptosi
may
induc
massiv
sudden
toxic
epiderm
necrolysi
local
gradual
erythema
multiformep
human
apoptosi
seem
key
mechan
lead
keratinocyt
death
tnf
major
cytokin
involv
apoptosisp
perforin
cytoplasm
peptid
contain
cytotox
lymphocyt
natur
killer
cell
suggest
playa
role
keratinocyt
apoptosisp
addit
role
calcium
regul
apoptosi
crucial
express
calprotectin
calciumbind
protein
increas
epidermi
patient
toxic
epiderm
necrolysiss
inform
led
hypothesi
toxic
drug
metabolit
stimul
keratinocyt
produc
tnf
perturb
calcium
homeostasi
lead
keratinocyt
apoptosi
absenc
inflammatori
cell
studi
suggest
upregul
keratinocyt
fa
cellsurfac
death
receptor
critic
trigger
keratinocyt
destructionf
dog
one
studi
could
demonstr
apoptosi
seven
case
toxic
epiderm
necrolysi
thought
epidermi
case
undergo
necrosi
patholog
mechan
differ
apoptosisp
appar
age
breed
sex
predilect
clinic
toxic
epiderm
necrolysi
usual
character
acut
onset
constitut
sign
pyrexia
anorexia
lethargi
depress
multifoc
gener
vesiculobul
diseas
see
fig
may
major
differenti
featur
erythema
multiform
human
case
toxic
epiderm
necrolysi
preced
pyrexia
vesicl
bulla
necrosi
result
ulcer
epiderm
collarett
may
found
anywher
skin
often
involv
oral
mucosa
mucocutan
junction
footpad
nikolski
sign
usual
present
cutan
pain
usual
moder
mark
differenti
diagnosi
rel
limit
sever
case
constitut
sign
acut
histori
includ
bum
system
lupu
erythematosu
sever
erythema
multiform
superfici
suppur
necrolyt
dermat
epitheliotrop
lymphoma
definit
diagnosi
base
histori
physic
examin
skin
biopsi
hemogram
usual
reveal
neutropenia
human
persist
neutropenia
portend
fatal
outcomel
histopatholog
find
toxic
epiderm
necrolysi
ident
regardless
underli
caus
consist
hydrop
degener
basal
epiderm
cell
fullthick
coagul
necrosi
epidermi
minim
dermal
inflamm
silent
dermi
cellpoor
inflamm
fig
dermoepiderm
separ
result
subepiderm
vesicl
fig
contrast
cellrich
inflamm
occur
erythema
multiformep
period
acidschiff
pa
posit
basement
membran
zone
present
usual
locat
floor
vesicl
infundibular
region
hair
follicl
outer
root
sheath
epithelium
may
similarli
affect
human
atrich
sweat
gland
duct
often
affect
studi
anim
must
emphas
toxic
epiderm
necrolysi
usual
definit
diagnosi
imper
rememb
toxic
epiderm
necrolysi
cutan
reaction
pattern
everi
attempt
must
made
find
underli
caus
result
direct
indirect
immunofluoresc
test
usual
neg
human
immunohistochem
studi
shown
cellpoor
infiltr
toxic
epiderm
necrolysi
contain
predominantli
macrophag
dermal
dendrocyt
unlik
cellrich
infiltr
rich
lymphocyt
found
erythema
multtformev
prognosi
toxic
epiderm
necrolysi
guard
poor
pend
identif
underli
caus
mortal
rate
high
human
mortal
greatest
idiopath
case
wherein
precipit
factor
recogn
specif
correct
sequela
prognosi
similar
massiv
seconddegre
bum
owe
fluid
electrolyt
colloid
loss
secondari
infect
sepsi
compound
loss
epiderm
barrier
function
mortal
rate
lower
therapi
human
conduct
specialti
treatment
center
bum
patient
treatment
consist
correct
underli
caus
symptomat
support
measur
eg
fluid
antibiot
topic
use
system
glucocorticoid
controversi
investig
think
drug
best
help
worst
detriment
incid
sepsi
result
higher
fatal
rate
greatest
concern
sever
extent
involv
may
relat
decis
whether
use
glucocorticoid
administr
system
glucocorticoid
may
indic
howev
druginduc
casesi
plasmapheresi
benefici
human
intraven
immunoglobulin
therapi
report
effect
human
presum
via
fa
blockadei
recoveri
depend
identif
correct
underli
caus
usual
occur
week
cutan
vascul
uncommon
disord
dog
character
purpura
often
palpabl
wheal
edema
papul
plaqu
nodul
alopecia
scar
necrosi
ulcer
often
involv
extrem
case
lesion
slightli
purpur
appear
erythemat
blanch
diascopi
cutan
vascul
rare
cat
vasculitid
classifi
histolog
neutrophil
eosinophil
lymphocyt
granulomat
mix
form
cellpoor
formsf
neutrophil
form
may
leukocytoclast
neutrophil
nuclei
undergo
karyorrhexi
result
nuclear
dust
nonleukocytoclasticl
dog
nonleukocytoclast
form
common
two
form
neutrophil
vascul
occurp
one
associ
skin
lesion
intraepiderm
pustul
follicul
neutrophil
spongiosi
pattern
may
associ
bacteri
skin
infect
drug
reaction
third
neutrophil
form
major
lesion
thrombosi
result
tissu
ischemia
pattern
often
associ
gramneg
septicemia
infect
target
endotheli
cellsp
eosinophil
vascul
associ
arthropod
reaction
food
hypersensit
eosinophil
granuloma
mast
cell
howev
vasculit
natur
eosinophilassoci
lesion
challengedv
interstiti
granulomat
dermat
vascul
associ
cyclosporin
administr
observ
dog
periocular
edema
alopecia
swell
base
one
ear
human
vascul
also
categor
size
affect
vessel
larg
small
though
consid
littl
valu
dog
cat
case
cutan
vascul
involv
small
dermal
blood
vessel
postcapillari
venul
vascul
occur
via
immun
nonimmun
mechanismsp
caus
cutan
diseas
vascul
commonli
thought
immunolog
mediat
result
drug
reaction
infectionf
pathomechan
cutan
vasculitid
assum
involv
type
iii
hypersensit
type
hypersensit
reaction
may
import
initi
immun
complex
deposit
blood
vessel
wall
howev
appear
complex
multipl
mechan
like
playa
role
postul
differ
membran
receptor
probabl
adhes
molecul
cytokin
immunoglobulin
complement
leukocyt
may
account
differ
histolog
appear
neutrophil
lymphocyt
vasculitid
addit
initi
neutrophilinduc
damag
endotheli
cell
could
result
express
self
antigen
whereupon
dendrit
cell
cell
could
initi
secondari
cellmedi
immun
respons
thu
perpetu
vascular
diseas
produc
lymphocytedomin
infiltratep
cutan
necrot
vascul
endotheli
cell
show
increas
express
icaml
eselectin
eselectin
adhes
molecul
neutrophil
case
form
vascul
associ
presenc
autoantibodi
react
neutrophil
cytoplasm
structur
eg
myeloperoxidas
endotheli
cell
cutan
vascul
may
associ
coexist
diseas
infect
food
hypersensit
insect
bite
malign
connect
tissu
disord
lupu
erythematosu
precipit
factor
infect
drug
vaccin
may
idiopath
case
infect
may
induc
immun
complex
septic
vascul
dog
treat
itraconazol
mglkglday
experi
cutan
vascul
lymphedema
andor
necrot
lesion
one
limb
wherea
dog
treat
mglkglday
experi
reactionp
focal
cutan
vascul
reaction
site
rabi
vaccin
describ
dog
rabi
viral
antigen
detect
blood
vessel
wallsf
retrospect
studi
cutan
vascul
dog
cat
food
hypersensit
diagnos
dog
advers
drug
reaction
dog
rabi
vaccin
reaction
dog
condit
idiopath
dog
cat
vaccinerel
vascul
certain
breed
may
predispos
jack
russel
terrier
scottish
terrier
german
shepherd
dog
greyhound
dachshund
hottweilersp
vaccin
reaction
commonli
recogn
poodl
silki
terrier
yorkshir
terrier
pekinges
maltes
may
reflect
breed
predilect
small
bodi
size
long
period
anagen
hair
growth
fuzzi
haircoat
phenotyp
breedsf
one
survey
two
four
case
bichon
breed
one
maltes
one
poodl
breed
associ
may
suggest
genet
compon
etiolog
form
vascul
suggest
human
hla
associationsp
skin
often
organ
system
involv
howev
organ
system
may
affect
wherein
skin
lesion
may
repres
initi
sign
system
diseas
skin
lesion
typic
occur
depend
area
bodi
skin
area
pressur
normal
wear
tear
skin
cover
extrem
pinna
tip
tail
forth
suscept
cold
environment
influenc
cutan
sign
vascul
usual
includ
palpabl
purpura
plaqu
hemorrhag
bulla
papul
pustul
necrosi
punchedout
crateriform
ulcer
occasion
acrocyanosi
especi
involv
extrem
paw
pinna
lip
tail
scrotum
oral
mucosa
may
clearli
associ
vascular
pathway
see
fig
g
fig
pinnal
lesion
often
preval
apex
concav
surfac
see
fig
hemorrhag
may
occur
within
claw
see
fig
pad
may
develop
central
punchedout
ulcer
see
fig
depress
scar
crust
plaqu
see
fig
gener
urticaria
may
occur
experi
well
result
one
studi
common
food
hypersensit
underli
etiolog
see
fig
edemat
plaqu
lymphedema
may
present
extrem
groin
see
fig
lesion
mayor
may
pain
anim
widespread
erythema
may
purplish
cyanot
occur
erythemat
skin
blanch
diascopi
confirm
purpur
natur
fig
rare
subcutan
nodul
note
repres
pannicul
caus
septal
vasculitisp
constitut
sign
may
present
includ
anorexia
depress
pyrexia
although
extracutan
sign
uncommon
polyarthropathi
myopathi
neuropathi
hepatopathi
thrombocytopenia
anemia
report
dog
cat
age
breed
sex
may
affect
prolif
thromhovascular
necrosi
pinna
recogn
dog
etiolog
unknown
appar
age
breed
sex
predilect
lesion
begin
apic
margin
pinna
spread
along
concav
surfac
elong
necrot
ulcer
center
lesion
often
thicken
scali
hyperpig
zone
surround
ulcer
fig
b
lesion
wedgeshap
wide
base
pinnal
apex
ulcer
enlarg
older
area
undergo
complet
necrosi
result
deform
pinnal
margin
focal
cutan
vascul
alopecia
site
rabi
vaccin
describ
dog
poodl
yorkshir
silki
terrier
appear
predispos
reaction
character
roughli
annular
area
variabl
alopecia
hyperpigment
less
commonli
scale
erythema
overli
variabl
indur
dermi
subcuti
caudal
later
thigh
wither
typic
affect
fig
lesion
gener
appear
month
subcutan
administr
vaccin
persist
month
year
cutan
renal
glomerular
vasculopathi
alabama
rot
greenetrack
diseas
describ
kennel
race
relat
unrel
greyhound
see
chap
age
month
year
sex
predilect
exist
palpabl
purpura
lesion
pinpoint
em
diamet
character
redden
area
rapidli
becom
dark
red
purpl
black
slough
lesion
multipl
commonli
occur
limb
less
commonli
groin
trunk
fig
within
day
lesion
ulcer
discharg
serosanguin
fluid
ulcer
welldemarc
usual
extend
subcuti
heal
slow
result
scar
format
within
month
mani
dog
experi
pit
edema
especi
distal
stifl
elbow
limb
ulcer
dog
new
lesion
develop
initi
lesion
resolv
dog
experi
pyrexia
lethargi
polydipsia
polyuria
vomit
dark
tarri
stool
acut
renal
failur
syndrom
thought
produc
verotoxin
shigalik
toxin
elabor
e
coli
contamin
raw
beef
product
similar
herrwlyticurem
syndrom
peopl
genet
predisposit
may
help
explain
suscept
creyhoundsp
famili
autosom
recess
trait
cutan
vasculopathi
german
shepherd
dog
report
young
puppi
dog
experi
pyrexia
lethargi
commonli
associ
swollen
depig
foot
pad
alopecia
crust
ulcer
may
also
occur
involv
pinna
tail
nasal
planum
footpad
biopsi
demonstr
vari
degre
combin
nodular
dermat
collagenolysi
vascular
degener
vascul
cellpoor
interfac
dermat
basal
cell
apoptosi
chang
may
partli
reflect
stage
diseas
time
biopsi
caus
determin
though
varieti
immunolog
test
result
normal
ischem
dermatopathi
syndrom
result
loss
blood
suppli
either
vascul
vasculopathi
case
relationship
vascul
vasculopathi
present
histopatholog
lesion
may
occur
case
may
reflect
stage
lesion
develop
time
sampl
syndrom
exemplifi
call
prototyp
form
ischem
dermatopathi
postrabi
vaccin
alopeciap
addit
lesion
canin
dermatomyos
thought
repres
ischem
dermatopathi
also
propos
vascular
diseas
consid
cellpoor
famili
german
shepherd
vasculopathi
lupoid
dermatos
diseas
creyhoundsp
date
report
primarili
associ
vaccin
reaction
lesion
occur
wider
distribut
site
vaccinationp
typic
postvaccin
lesion
visibl
site
inject
month
vaccin
multipl
multifoc
lesion
develop
within
month
appear
inject
site
lesion
lesion
variou
combin
plaqu
nodul
alopecia
scale
eros
ulcer
crust
hyperpigment
scar
see
fig
lesion
may
occur
site
vaccin
pinna
usual
apex
often
concav
surfac
especi
pinnal
margin
face
paw
pad
tip
tail
periocular
region
boni
promin
eros
ulcer
may
seen
tongu
associ
ischem
atroph
myopathi
may
present
differenti
diagnosi
includ
coagulopathi
system
lupu
erythematosu
cold
agglutinin
diseas
frostbit
dissemin
intravascular
coagul
lymphoreticular
neoplasia
urticari
lesion
predomin
hypersensit
disord
associ
vascul
also
differenti
diagnos
definit
diagnosi
base
histori
physic
examin
skin
biopsi
histopatholog
reveal
vari
degre
neutrophil
eosinophil
lymphocyt
vascul
fig
possibl
reflect
age
lesion
type
immunoreactantsw
fibrinoid
necrosi
usual
present
involv
deep
dermal
vessel
may
suggest
system
diseas
deep
vasculatur
affect
necrosi
appendag
subcutan
fat
may
occur
lesion
like
show
diagnost
chang
hour
old
biopsi
diagnosi
vascul
vasculopathi
suspect
basi
cellpoor
hydrop
interfac
dermat
mural
follicul
loss
definit
stain
intens
ultim
atrophi
necrosi
hair
follicl
fade
follicl
fig
sebac
sweat
gland
may
similarli
less
frequent
affect
hyalin
dermal
collagen
hypovascular
demonstr
decreas
factor
viii
stain
blood
vessel
may
presentp
diagnosi
cutan
vascul
establish
imper
underli
etiolog
factor
sought
elimin
tabl
cutan
vascul
report
dog
bacteremia
system
lupu
erythematosu
rheumatoid
arthriti
polyarter
nodosa
rocki
mountain
spot
fever
ehrlichiosi
babesiosi
leishmaniasi
sarcocystosi
parvoviru
coronaviru
infect
drug
reaction
vaccin
reaction
staphylococc
hypersensit
idiopath
occurr
addit
lymphocyt
eosinophil
vascul
recogn
dog
drug
reaction
sever
scabi
flea
bite
hypersensit
food
hypersensit
arthropod
bitesstingsf
cat
cutan
vascul
associ
drug
administr
vaccin
rabi
herp
viruscalictviruspanleukopenia
infect
felv
fiv
fip
idiopathyf
prolif
thrombovascular
necrosi
pinna
character
arteriolar
prolifer
sclerosi
hyalin
degener
eventu
thrombosisp
inflammatori
vascul
present
focal
vascul
alopecia
subsequ
rabi
vaccin
character
vascul
affect
arteriol
deep
dermi
subcuti
septal
pannicul
fat
necrosi
focal
lymphoid
nodul
mark
atrophi
necrosi
overli
adnexa
see
fig
fig
cutan
renal
glomerular
vasculopathi
character
mild
sever
chang
arteriol
arteri
deep
dermi
subcutisf
chang
rang
increas
eosinophilia
tunica
media
pyknosi
karyorrhexi
occasion
fibrinoid
necrosi
vascular
thrombosi
ischemia
result
purpura
cutan
infarct
mani
affect
greyhound
especi
azotemia
thrombocytopenia
normocyt
normochrom
anemia
hypoalbuminemia
increas
serum
creatin
kinas
activ
direct
immunofluoresc
immunohistochem
test
may
demonstr
immunoglobulin
complement
vessel
wall
occasion
basement
membran
zone
neutrophil
lymphocyt
form
cutan
vascul
see
fig
human
common
immunoreact
igm
fibrin
granular
pattern
within
vessel
wali
test
usual
need
howev
particularli
use
diagnosi
perform
best
done
within
first
hour
lesion
format
later
hoursf
studi
human
shown
intraderm
inject
ml
histamin
phosphat
solut
skin
patient
activ
cutan
vascul
reliabl
method
demonstr
deposit
immunoreact
direct
immunofluoresc
test
inject
site
perform
hour
inject
dog
activ
vascul
may
increas
level
circul
immun
complex
decreas
level
serum
complement
hypergammaglobulinemiay
difficult
predict
cours
diseas
individu
case
singl
episod
last
week
may
occur
disord
may
chronic
recurr
outcom
depend
extent
intern
organ
involv
especi
renal
neurolog
underli
precipit
factor
treatment
vascul
consist
correct
underl
caus
immunomodulatori
drug
treatment
less
sever
case
initi
therapi
pentoxifyllin
indic
rel
lack
side
effect
report
success
see
chap
pentoxifyllin
appar
effect
four
seven
rabi
vaccineassoci
vasculitid
requir
month
therapi
benefit
leukocytoclast
vasculitidesp
sever
case
vascul
especi
neutrophil
type
system
prednison
prednisolon
mglkg
oral
initi
use
without
pentoxifyllinef
case
refractori
glucocorticoid
sulfon
dapson
mgkg
oral
dog
mgkg
oral
caution
cat
sulfasalazin
mgkg
oral
dog
may
effectivef
combin
glucocorticoid
dapson
may
larg
dose
vitamin
e
may
use
adjunct
cyclophosphamid
use
patientst
colchicin
often
benefici
humansl
azathioprin
effect
dog
combin
tetracyclin
niacinamidep
case
therapi
stop
month
treatment
patient
requir
longterm
mainten
therapi
lower
drug
dose
reduc
frequenc
administr
see
chap
vascul
occur
itraconazol
therapi
often
elimin
reduc
dose
mgkgday
mglkgday
see
chap
prolif
thrombooascular
necrosi
pinna
slowli
progress
usual
unrespons
medic
therapi
tri
anecdot
report
suggest
pentoxifyllin
combin
tetracyclin
niacinamid
occasion
experi
pentoxifyllin
help
total
success
thrombot
pinnal
diseas
possibl
effect
increas
peripher
perfus
andor
antiinflammatori
effect
pentoxifyllin
ineffect
treatment
choic
partial
surgic
remov
pinna
relaps
occur
attempt
made
save
much
tissu
possibl
focal
cutan
vascul
alopecia
subsequ
inject
may
also
respond
reduct
lesion
size
pentoxifyllin
may
treat
complet
surgic
excis
occasion
spontan
resolvesv
would
logic
repeat
incrimin
vaccin
unless
requir
one
could
avoid
local
vaccin
reaction
give
product
intramuscularli
gener
reaction
would
still
possiblep
linear
iga
pustular
dermatosi
rare
idiopath
steril
superfici
pustular
dermatosi
dachshund
character
histolog
subcorn
pustul
immunolog
deposit
iga
basement
membran
zone
affect
skin
analog
similarli
name
dermatosi
humansf
clinic
linear
iga
pustular
dermatosi
character
multifoc
gener
pustular
dermat
trunk
typic
involv
secondari
skin
lesion
includ
annular
area
alopecia
eros
epiderm
collarett
hyperpigment
scale
crust
see
fig
pruritu
minim
absent
dog
otherwis
healthi
case
date
recogn
adult
dachshund
either
sex
differenti
diagnosi
includ
bacteri
follicul
dermatophytosi
demodicosi
pemphigu
foliaceu
subcorn
pustular
dermatosi
cytolog
examin
pu
reveal
nondegener
neutrophil
microorgan
occasion
acantholyt
keratinocyt
diagnosi
base
cultur
neg
skin
biopsi
intraepiderm
pustular
dermat
numer
non
degener
neutrophil
minim
acantholysi
fig
direct
immunofluoresc
immunohistochem
test
iga
deposit
basement
membran
zone
therapi
consist
larg
dose
prednisolon
prednison
mglkg
oral
alternateday
regimen
dapson
mgikg
oral
need
see
chap
interestingli
glucocorticoid
may
work
one
case
anoth
true
dapson
uveodermatolog
syndrom
vogtkoyanagiharadalik
syndrom
rare
idiopath
syndrom
concurr
granulomat
uveiti
depig
dermat
caus
syndrom
unknown
syndrom
similar
vogtkoyanagiharada
syndrom
human
current
thought
repres
autoimmun
disord
human
cellmedi
hypersensit
melanin
melanocyt
demonstr
antibodi
melanin
gangliosid
photoreceptorss
antiretin
antibodi
demonstr
dog
human
vogtkoyanagiharada
syndrom
three
phase
meningoencephalit
phase
prodromata
fever
malais
headach
tinnitu
nausea
vomit
ophthalm
phase
photophobia
uveiti
decreas
visual
acuiti
potenti
blind
dermatolog
phase
poliosi
case
alopecia
vitiligo
dermatolog
sign
usual
symmetr
especi
involv
head
neck
eyelid
usual
mark
convalesc
stage
uveiti
begin
abat
pigmentari
chang
tend
perman
dog
appar
age
month
year
sex
predilect
akita
chow
samoy
siberian
huski
appear
predlspos
pe
syndrom
usual
character
acut
onset
uveiti
concurr
subsequ
depigment
nose
lip
eyelid
occasion
footpad
scrotum
prepuc
anu
hard
palat
see
fig
f
cutan
lesion
usual
appear
within
day
recognit
ocular
lesion
occasion
occur
sever
month
later
one
dog
concurr
onychomadesi
oral
ulcer
rare
case
skin
lesion
mild
consist
welldemarc
depigment
without
mild
erythema
scale
case
howev
progress
even
rapidli
develop
mark
dermat
depig
area
develop
vari
degre
eros
ulcer
crust
perhap
dermat
may
associ
exposur
sunlight
photodermatitisj
patchi
leukotrichia
may
present
area
surround
cutan
depigment
rare
leukoderma
leukotrichia
widespreadp
clinicopatholog
evid
meningoencephalit
phase
rare
dog
though
one
case
second
cranial
nerv
deficit
report
clinic
sign
refer
uveiti
anterior
posterior
may
includ
photophobia
blepharospasm
lacrim
conjunctiv
congest
corneal
edema
retin
detach
glaucoma
cataract
blindnessv
definit
diagnosi
base
histori
physic
examin
skin
biopsi
histopatholog
find
specimen
taken
earli
skin
lesion
character
lichenoid
interfac
dermat
wherein
larg
histiocyt
major
cellular
compon
fig
pigmentari
incontin
pronounc
hydrop
degener
epiderm
basal
cell
rare
cytolog
aqueou
humor
one
case
reveal
infiltr
predominantli
macrophag
histopatholog
find
eye
includ
granulomat
panuv
retin
degen
chang
optic
nerv
tract
may
occurp
result
direct
indirect
immunofluoresc
test
usual
neg
patient
poorli
control
uveiti
often
experi
posterior
synechia
secondari
glaucoma
cataract
vision
loss
thu
aggress
earli
treatment
essenti
topic
subconjunctiv
glucocorticoid
topic
cyclopleg
eg
atropin
benefici
patient
anterior
uveiti
system
glucocorticoid
azathioprin
need
combat
posterior
uveiti
dermatolog
sign
topic
cyclosporin
use
one
dog
diseas
treat
earli
variabl
degre
cutan
repigment
sometim
complet
usual
occur
occasion
case
may
respond
system
glucocorticoid
alon
blind
may
result
delay
effect
therapi
aggress
therapi
often
requir
recommend
combin
immunosuppress
dog
usual
requir
longterm
alternatemorn
oral
glucocorticoid
therapi
eg
mglkg
prednison
prednisolon
prevent
recurrencep
seen
good
respons
combin
tetracyclin
niacinamid
see
chap
drug
combin
allow
mark
reduct
discontinu
system
glucocorticoid
therapi
respons
skin
lesion
use
assess
respons
therapi
uveiti
may
activ
skin
improvingp
ophthalm
examin
period
perform
even
cutan
chang
remiss
auricular
chondriti
relaps
polychondr
rare
diseas
cat
dog
character
inflamm
destruct
auricular
cartilag
human
somewhat
similar
condit
call
relaps
polychondr
howev
cat
auricular
cartilag
affect
condit
report
relaps
natur
henc
cat
term
relaps
polychondr
present
inappropriatev
relaps
polychondr
often
classifi
among
immunemedi
diseas
similar
rheumatoid
arthriti
lupu
erythematosu
well
favor
respons
immunomodulatori
therapi
human
antibodi
type
ii
collagen
may
demonstr
case
one
dog
definit
caus
determin
though
chronic
otiti
preced
develop
auricular
chondritisp
affect
cat
one
dog
present
histori
swollen
erythemat
pain
ear
examin
pinna
swollen
meati
erythemat
violac
curl
deform
see
fig
h
fig
typic
pinna
affect
although
one
may
sever
affect
condit
may
initi
unilater
bilateralp
cat
may
otherwis
healthi
may
show
sign
pyrexia
lethargi
anorexia
cat
age
year
sex
breed
predilect
evidentp
dog
histori
noneros
polyarthr
laxiti
digit
carpal
joint
well
otiti
prior
develop
auricular
chondriti
biopsi
reveal
lymphoplasmacyt
inflamm
loss
cartilag
basophilia
cartilag
necrosi
fig
hematolog
examin
may
demonstr
variabl
degre
neutrophilia
lymphocytosi
hyperglobulinemia
one
cat
posit
ana
also
concurr
fiv
infectionp
direct
immunofluoresc
test
neg
two
catsf
cat
pain
show
system
sign
may
fine
without
therapi
system
glucocorticoid
ineffect
eight
cat
dapson
mglkg
induc
remiss
four
cat
relaps
occur
therapi
stop
perman
deform
pinna
expect
whether
cat
treat
surgic
excis
effect
elimin
discomfort
gross
lesion
one
dog
immunoprolif
enteropathi
basenji
character
chronic
intract
diarrhea
progress
emaci
autosom
recess
inherit
condit
hypothes
similar
diseas
exist
human
basenji
either
sex
wide
age
rang
affect
skin
lesion
variabl
may
consist
alopecia
hyperpigment
hyperkeratosi
margin
necrosi
ulcer
pinna
symmetr
alopecia
ventrum
haircoat
often
dri
dull
diagnosi
base
histori
physic
examin
laboratori
test
affect
dog
hypergammaglobulinemia
dog
hypothyroid
intestin
biopsi
reveal
lymphoplasmacyt
enter
dermatohistopatholog
find
nondiagnost
alopec
skin
character
endocrinopath
chang
probabl
reflect
hypothyroid
dermatit
pinna
character
ulcer
perivascular
dermat
necrosi
chang
consist
secondari
bacteri
infect
although
clinic
appear
pinna
suggest
vasculopathi
histolog
evid
vessel
diseas
report
therapi
provid
accord
symptom
often
disappoint
genet
counsel
avoid
stress
highqual
commerci
diet
indic
system
glucocorticoid
may
benefici
alopecia
areata
uncommon
disord
dog
cat
character
patch
nonscar
hair
loss
grossli
noninflammatori
alopecia
areata
complex
pathogenesi
immunolog
target
anagen
hair
follicl
rel
consist
find
antifollicular
autoantibodi
igg
class
well
cell
affect
follicl
humansf
lymphocyt
antifollicular
antibodi
also
document
dog
dog
autoantibodi
direct
trichohyalin
inner
root
sheath
hair
matrix
antigen
differ
find
human
mice
wherein
outer
root
sheath
hair
matrix
often
targetedf
perifollicular
lymphocyt
intrabulbar
cell
describ
dog
addit
mani
dendrit
antigenpres
cell
present
perifollicular
dermisf
observ
human
support
immunolog
basi
accumul
lymphoid
cell
helper
cell
around
hair
bulb
activ
phase
diseas
occasion
associ
alopecia
areata
immunemedi
diseas
increas
incid
variou
autoantibodi
alopecia
areata
decreas
number
circul
cell
abnorm
presenc
langerhan
cell
follicular
bulb
increas
express
class
ii
mhc
antigen
deposit
igg
igm
basement
membran
zone
hair
follicl
lesion
normal
scalp
reveal
direct
immunofluoresc
test
therapeut
benefit
induc
delayedtyp
hypersensit
immunosuppress
therapi
addit
genet
endocrin
psycholog
factor
thought
play
role
human
alopecia
areat
morpholog
abnorm
melanocyt
follicular
bulb
describ
human
alopecia
areata
cytokin
tnfa
potent
inhibitor
hair
follicl
growth
vitro
produc
chang
hair
follicl
morpholog
similar
alopecia
areata
dog
cat
alopecia
areata
character
focal
multifoc
patch
asymptomat
noninflammatori
alopeciap
appar
age
sex
predilect
though
case
report
dachshund
may
overrepres
alopec
area
well
circumscrib
expos
skin
appear
normal
fig
chronic
alopec
area
may
becom
variabl
hyperpig
lesion
may
occur
anywher
especi
head
neck
trunk
lesion
may
solitari
numer
may
asymmetr
symmetr
rare
alopecia
progress
involv
major
bodi
fig
hair
growth
may
occur
spontan
initi
regrown
hair
white
later
replac
pigment
hair
fig
microscop
examin
hair
pluck
margin
enlarg
lesion
reveal
mixtur
normal
telogen
dysplast
exclam
point
hairsshort
stubbi
hair
fray
fractur
pigment
distal
end
whose
shaft
undul
taper
toward
proxim
end
fig
occasion
alopecia
areata
may
confin
darkhair
area
multicolor
haircoat
fig
claw
chang
compat
trachyonychia
roughen
ridg
vertic
striation
seen
one
dog
compar
occasion
occur
human
alopecia
areata
differenti
diagnosi
includ
traction
alopecia
inject
reaction
acquir
pattern
alopecia
topic
steroid
reaction
follicular
dysplasia
dermatophytosi
demodicosi
staphi
lococc
follicul
pseudopelad
psychogen
alopecia
endocrinopathi
definit
diagnosi
base
insidi
onset
asymptomat
wellcircumscrib
area
noninflammatori
alopecia
skin
biopsi
characterist
earli
histopatholog
find
includ
peribulbar
accumul
lymphocyt
histiocyt
plasma
cell
describ
look
like
swarm
bee
fig
earli
chang
may
difficult
demonstr
specimen
may
show
inflammatori
cell
apoptosi
bulbar
keratinocyt
find
help
diagnost
lesion
aid
perform
multipl
biopsi
advanc
edg
earli
lesion
later
histopatholog
find
consist
predomin
catagen
telogen
hair
follicl
well
follicular
atrophi
hair
follicl
may
distort
contour
follicular
hair
shaft
dysplasia
peribulbar
pigmentari
incontin
chronic
lesion
may
show
complet
absenc
hair
follicl
fibrou
tract
associ
orphan
epitrichi
sweat
sebac
gland
arrector
pili
muscl
humansf
eosinophil
may
found
peribulbar
infiltr
within
fibrou
tract
dog
alopecia
areata
prognosi
alopecia
areata
human
usual
good
patient
recov
complet
within
year
without
therapi
although
topic
intralesion
system
glucocorticoid
often
recommend
treatment
alopecia
areata
human
dog
cat
anecdot
evid
beneficial
biolog
behavior
alopecia
areata
dog
cat
unclear
dog
cat
one
lesion
spontan
recov
cours
month
year
initi
hair
regrowth
often
color
lighter
normal
leukotrichia
varieti
immunomodulatori
therapi
use
human
mice
includ
corticosteroid
contact
sensit
cyclosporin
minoxidil
uv
exposur
without
concurr
psoralen
therapyl
dachshund
alopecia
pinna
around
eye
black
hair
lost
tan
hair
muzzl
eyebrow
retain
pseudopelad
rare
disord
dog
cat
character
alopecia
grossli
noninflammatori
pseudopelad
appear
immunemedi
pathogenesi
immunolog
studi
conduct
skin
biopsi
two
dog
one
cat
shown
predomin
lymphocyt
within
epithelium
hair
follicl
isthmu
perifollicular
dermi
rich
lymphocyt
well
cdi
dendrit
antigenpres
cell
circul
autoantibodi
igg
class
multipl
lower
hair
follicl
protein
includ
hair
keratin
trichohyalin
demonstr
four
dog
cat
pseudopelad
describ
dog
appar
breed
sex
predilectionsp
lesion
character
wellcircumscrib
noninflammatori
area
alopecia
vari
em
diamet
one
bodi
area
diffus
alopecia
spare
head
neck
lesion
scali
andor
hyperpig
pruritu
constitut
sign
absent
cat
present
moreorless
symmetr
noninflammatori
alopecia
may
begin
face
fig
spread
ventrum
leg
paw
fig
onychomadesi
constant
find
see
fig
differenti
diagnosi
describ
alopecia
areata
definit
diagnosi
base
skin
biopsi
histopatholog
differenti
diagnosi
includ
entiti
character
lymphocyt
mural
follicul
see
chap
characterist
earli
histopatholog
find
includ
variabl
sever
accumul
lymphocyt
histiocyt
fewer
plasma
cell
intens
follicular
isthmu
fig
cat
small
number
neutrophil
eosinophil
may
also
present
earli
lesion
inflamm
mark
atroph
chang
mild
absent
sebac
gland
present
late
lesion
atroph
chang
sever
inflamm
mild
sebac
gland
often
absent
condit
fail
respond
topic
system
glucocorticoid
well
chlorambucilf
cat
anecdot
report
indic
cyclosporin
may
effect
spontan
remiss
report
amyloidosi
gener
term
signifi
abnorm
extracellular
deposit
one
famili
unrel
protein
share
certain
characterist
stain
properti
ultrastructur
featuresp
amyloidosi
singl
diseas
entiti
amyloid
may
accumul
result
varieti
differ
pathogenet
mechan
dog
cat
case
amyloidosi
relat
deposit
immunoglobulin
light
chain
differ
amino
acid
composit
amyloid
may
occur
amyloid
deposit
contain
nonfibrillar
protein
call
amyloidp
ident
normal
circul
plasma
globulin
known
serum
amyloidp
elastas
inhibitor
may
help
protect
amyloid
deposit
degrad
phagocytosi
primari
myelomaassoci
system
amyloidosi
immunoglobulin
light
chain
mostli
lambda
type
precursor
amyloid
fibril
protein
call
amyloidl
secondari
system
amyloidosi
associ
chronic
inflamm
serum
precursor
protein
serum
amyloida
highdens
lipoprotein
acutephas
reactant
form
fibril
amyloid
deposit
serum
amyloida
thought
cleav
proteolyt
macrophag
amyloida
excret
extracellularli
although
pathogenesi
amyloidosi
unclear
morpholog
relat
cell
mononuclear
phagocyt
system
plasma
cell
keratinocyt
function
studi
suggest
cell
play
least
partial
role
genesi
amyloidosi
ultim
amyloid
deposit
lead
chang
tissu
architectur
function
dog
cat
amyloidosi
usual
associ
chronic
inflammatori
diseas
neoplasia
accumul
plasma
cell
also
associ
vasculit
syndromep
also
suggest
vaccin
reaction
caus
polyarthr
akita
progress
renal
amyloidosisi
famili
tendenc
detect
chines
shar
pei
beagl
dog
abyssinian
siames
cat
commonli
amyloidosi
intern
diseas
usual
affect
kidney
spleen
liver
death
often
result
renal
involv
cutan
lesion
describ
dog
system
amyloidosi
primari
cutan
diseasep
cutan
ou
lesion
system
amyloidosi
associ
monoclon
gammopathi
report
adult
femal
cocker
cutan
hemorrhag
could
induc
flick
abdomin
skin
briskli
finger
remov
hair
fig
skin
traumat
sever
blood
ooz
skin
within
second
clot
immedi
skin
biopsi
reveal
amorph
homogen
eosinophil
superfici
dermi
wall
blood
vessel
involv
area
thicken
deposit
homogen
eosinophil
materi
fig
materi
congo
redposit
congophilia
green
birefring
materi
visibl
congo
redstain
section
examin
polar
light
dichroism
monoclon
serum
igg
paraprotein
found
treatment
given
dog
remain
unchang
month
mucocutan
amyloidosi
unassoci
monoclon
gammopathi
report
brittani
spaniel
dog
multipl
whitish
ulcer
papular
plaquelik
lesion
tongu
gingiva
well
ooz
ulcer
footpad
ventral
surfac
interdigit
space
multipl
pressur
point
elbow
stifl
case
gener
amyloidosi
describ
loweekold
german
shepherd
present
swollen
erythemat
pad
reluct
walk
though
amyloidosi
found
necropsi
pad
show
chronic
exud
inflamm
primari
nodular
cutan
amyloidosi
describ
common
type
cutan
amyloidosi
dog
cat
solitari
group
dermal
subcutan
nodul
may
occur
anywher
commonli
involv
ear
nodul
may
ulcer
secondari
necrosi
human
nodular
amyloidosi
consid
plasmacytoma
local
produc
immunoglobulin
light
chain
precursor
amyloid
fibril
may
case
dog
well
differenti
diagnosi
lesion
would
neoplasia
cyst
infecti
steril
nodular
granuloma
diagnosi
made
histopatholog
examin
show
multipl
dermal
accumul
amorph
eosinophil
materi
small
number
plasma
cell
found
well
macrophag
small
number
lymphocyt
diagnosi
amyloidosi
confirm
lightmicroscop
examin
reveal
deposit
eosinophil
amorph
substanc
congophil
birefring
polar
fig
secondarybut
primari
myelomaassociatedamyloid
lose
congophilia
pretreat
potassium
permangan
electronmicroscop
examin
reveal
characterist
presenc
linear
nonbranch
tubular
fibril
fibril
compos
sever
filament
arrang
bpleat
sheet
configurationp
solitari
nodul
un
associ
system
diseas
success
excis
success
treatment
multipl
lesion
report
human
skin
lesion
primari
myelomaassoci
amyloidosi
respond
dmso
may
inhibit
amyloid
synthesi
act
promot
amyloid
degradationp
figur
canin
cutan
amyloidosi
multipl
lake
homogen
fractur
amyloid
